Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 8, "Indicator": "Acute Phase Treatment", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 9, "Indicator": "Continuation Phase Treatment", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.3, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 10, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 11, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 12, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 29, "Indicator": "Rate", "state": "Alabama", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 30, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. State attributes lower rate to missing information about blood pressure results in administrative data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 31, "Indicator": "LARC", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.9, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. State used hospital claims data, case management data, and maternity claims data in addition to the measure value set to capture the number of deliveries.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 32, "Indicator": "LARC", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 9.5, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. State used hospital claims data, case management data, and maternity claims data in addition to the measure value set to capture the number of deliveries.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 33, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. State used hospital claims data, case management data, and maternity claims data in addition to the measure value set to capture the number of deliveries.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 34, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.7, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. State used hospital claims data, case management data, and maternity claims data in addition to the measure value set to capture the number of deliveries.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 43, "Indicator": "Rate", "state": "Alabama", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 44, "Indicator": "LARC", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 45, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 29, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 50, "Indicator": "Rate", "state": "Alabama", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 57, "Indicator": "Rate", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 20.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 60, "Indicator": "30-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.6, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 61, "Indicator": "7-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.8, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 62, "Indicator": "30-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.5, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 63, "Indicator": "7-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 32.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 68, "Indicator": "30-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.5, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 69, "Indicator": "7-Day Follow-Up", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.1, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 70, "Indicator": "Rate", "state": "Alabama", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 39.7, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 71, "Indicator": "Initiation", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 86, "Indicator": "Discussing Cessation Medications", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 42.9, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 87, "Indicator": "Discussing Cessation Strategies", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 37.6, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 88, "Indicator": "Rate", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.1, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 90, "Indicator": "Rate", "state": "Alabama", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.9, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. State used hospital claims data, case management data, and maternity claims data in addition to the measure value set to capture the number of deliveries.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 93, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 94, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 212.7, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 95, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.7, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 96, "Indicator": "Rate", "state": "Alabama", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.9, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 97, "Indicator": "Rate", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 79.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 100, "Indicator": "Rate", "state": "Alabama", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 77.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 145, "Indicator": "Acute Phase Treatment", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 42.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 146, "Indicator": "Continuation Phase Treatment", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.7, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 147, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 148, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 149, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 55.6, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 158, "Indicator": "Rate", "state": "Arizona", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 159, "Indicator": "LARC", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.7, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 160, "Indicator": "LARC", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 9.8, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 161, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 8.2, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 162, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 35.5, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 167, "Indicator": "Rate", "state": "Arizona", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 49.3, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 168, "Indicator": "LARC", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 5.3, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 169, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arizona", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 24.5, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 172, "Indicator": "Rate", "state": "Arizona", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 54, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 174, "Indicator": "Rate", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 8.8, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 176, "Indicator": "30-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 28.3, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 177, "Indicator": "7-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.3, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 178, "Indicator": "30-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 70.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates include services provided by additional provider types, including federally qualified health centers, regional health centers, integrated care clinics, and behavioral health outpatient clinics. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 179, "Indicator": "7-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.8, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates include services provided by additional provider types, including federally qualified health centers, regional health centers, integrated care clinics, and behavioral health outpatient clinics. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 182, "Indicator": "30-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 59.3, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 183, "Indicator": "7-Day Follow-Up", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 46, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 184, "Indicator": "Initiation", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 41.1, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 194, "Indicator": "Observed/Expected Ratio", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1.0588, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population. Rates are provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 196, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 15.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 197, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 41.3, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 198, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 27.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 199, "Indicator": "Rate", "state": "Arizona", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 7.3, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 200, "Indicator": "Rate", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.4, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 202, "Indicator": "Rate", "state": "Arizona", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 79.9, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population. Rate is provisional. State conducted an internal audit of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 208, "Indicator": "Acute Phase Treatment", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 39.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 209, "Indicator": "Continuation Phase Treatment", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 210, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 39.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 211, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 38.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 212, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 35.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 221, "Indicator": "LARC", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.3, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 222, "Indicator": "LARC", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.1, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 223, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.2, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 224, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 38.1, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 229, "Indicator": "Rate", "state": "Arkansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 230, "Indicator": "LARC", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3.3, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 231, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Arkansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 23.1, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 234, "Indicator": "Rate", "state": "Arkansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 61.6, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 238, "Indicator": "Rate", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 22.3, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 239, "Indicator": "30-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.3, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 240, "Indicator": "7-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 241, "Indicator": "30-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 42, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 242, "Indicator": "7-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 24.4, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 245, "Indicator": "30-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 39.2, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 246, "Indicator": "7-Day Follow-Up", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 21.9, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 248, "Indicator": "", "state": "Arkansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 89.2, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community and Employment Support (CES) waiver. Funding sources include HCBS and Combination HCBS 1915(b)(c) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,079. State used a proportionate sample by supported living providers.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 249, "Indicator": "", "state": "Arkansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 56.2, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community and Employment Support (CES) waiver. Funding sources include HCBS and Combination HCBS 1915(b)(c) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,079. State used a proportionate sample by supported living providers.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 250, "Indicator": "", "state": "Arkansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community and Employment Support (CES) waiver. Funding sources include HCBS and Combination HCBS 1915(b)(c) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,079. State used a proportionate sample by supported living providers.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 251, "Indicator": "Rate", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.4, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 252, "Indicator": "Observed/Expected Ratio", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.8906, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (3 MCOs). Rates exclude 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rates were audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 254, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 37.3, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 255, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 121.7, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 256, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 47.1, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 257, "Indicator": "Rate", "state": "Arkansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 258, "Indicator": "Rate", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.4, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 260, "Indicator": "Rate", "state": "Arkansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 80.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (3 MCOs). Rate excludes 1115 waiver population and Medicare-Medicaid Dual Eligibles. Rate was audited by the state's data contractor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 263, "Indicator": "Rate", "state": "California", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 92.4, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (25 MCOs), representing 77 percent of the population. Rate excludes FFS population and beneficiaries who were not in the same MCO for the entire continuous enrollment period, representing 23 percent of the population. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and 23 MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 267, "Indicator": "Acute Phase Treatment", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.1, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 268, "Indicator": "Continuation Phase Treatment", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.8, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 269, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 270, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.1, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 271, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.4, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 280, "Indicator": "Rate", "state": "California", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 63.7, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 281, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 61.1, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. The administrative method was used for two MCOs and the FFS population and 23 MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 282, "Indicator": "LARC", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.9, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 283, "Indicator": "LARC", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 6.5, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 284, "Indicator": "Most or Moderately Effective Contraceptive", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 9.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 285, "Indicator": "Most or Moderately Effective Contraceptive", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 31.8, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 290, "Indicator": "Rate", "state": "California", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 60, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. The administrative method was used for two MCOs and the FFS population and 23 MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 291, "Indicator": "LARC", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 4.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 292, "Indicator": "Most or Moderately Effective Contraceptive", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.4, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 295, "Indicator": "Rate", "state": "California", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 68.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rates was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 299, "Indicator": "Rate", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.2, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 301, "Indicator": "30-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 14.2, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 302, "Indicator": "7-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 303, "Indicator": "30-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 69.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 304, "Indicator": "7-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 307, "Indicator": "30-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 62.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 308, "Indicator": "7-Day Follow-Up", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 309, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 36.5, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (25 MCOs), representing 77 percent of the population. Rate excludes FFS population, representing 23 percent of the population and beneficiaries who were not in the same MCO for the entire continuous enrollment period. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and 23 MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 310, "Indicator": "Initiation", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.4, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 322, "Indicator": "Observed/Expected Ratio", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.9769, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (25 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 324, "Indicator": "Rate", "state": "California", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative & Hybrid", "state_rate": 72.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Three MCOs and the FFS population used the administrative method and 22 MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 326, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.6, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 327, "Indicator": "Rate", "state": "California", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 328, "Indicator": "Rate", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.5, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 330, "Indicator": "Rate", "state": "California", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 77.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (25 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 336, "Indicator": "Acute Phase Treatment", "state": "Colorado", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 64.2, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (2 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 337, "Indicator": "Continuation Phase Treatment", "state": "Colorado", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.8, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (2 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 338, "Indicator": "Rate", "state": "Colorado", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (2 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 339, "Indicator": "Rate", "state": "Colorado", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (2 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 340, "Indicator": "Rate", "state": "Colorado", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (2 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 342, "Indicator": "Rate", "state": "Colorado", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.9, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (2 MCOs) ages 50 to 74. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 343, "Indicator": "LARC", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.5, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 344, "Indicator": "LARC", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 15.4, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 345, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 346, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.6, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 351, "Indicator": "LARC", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 352, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Colorado", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21.1, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 360, "Indicator": "", "state": "Colorado", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 89.9, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Persons with Developmental Disabilities Program and Supported Living Services waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 10,717. State used a proportionate sample by waiver program and Regional Accountable Entities (RAEs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 361, "Indicator": "", "state": "Colorado", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 78.3, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Persons with Developmental Disabilities Program and Supported Living Services waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 10,717. State used a proportionate sample by waiver program and Regional Accountable Entities (RAEs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 362, "Indicator": "", "state": "Colorado", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 95.8, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Persons with Developmental Disabilities Program and Supported Living Services waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 10,717. State used a proportionate sample by waiver program and Regional Accountable Entities (RAEs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 364, "Indicator": "Rate", "state": "Colorado", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations, representing 89 percent of the population. Rate excludes managed care population, representing 11 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 367, "Indicator": "Rate", "state": "Connecticut", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 87.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 232,701. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 371, "Indicator": "Acute Phase Treatment", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 58.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 372, "Indicator": "Continuation Phase Treatment", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.9, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 373, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 61.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 374, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 62.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 375, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 65, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 384, "Indicator": "Rate", "state": "Connecticut", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 385, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 61, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 50,909. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 386, "Indicator": "LARC", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 5.4, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 387, "Indicator": "LARC", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.6, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 388, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.1, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 389, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 46.3, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 394, "Indicator": "Rate", "state": "Connecticut", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 69, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 165,504. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 395, "Indicator": "LARC", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 5.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 396, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 29.9, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 399, "Indicator": "Rate", "state": "Connecticut", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 72.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 403, "Indicator": "Rate", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 2.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 405, "Indicator": "30-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 32.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 406, "Indicator": "7-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 18.9, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 407, "Indicator": "30-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 65.4, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 408, "Indicator": "7-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 44.5, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 411, "Indicator": "30-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 412, "Indicator": "7-Day Follow-Up", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 42.3, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 413, "Indicator": "Rate", "state": "Connecticut", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 47.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 414, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 36.9, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 33,545. Rate was audited by certified HEDIS auditor. Due to the COVID-19 public health emergency, state reported using FFY 2019 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 415, "Indicator": "Initiation", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 40.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 427, "Indicator": "Discussing Cessation Medications", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 53.3, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 428, "Indicator": "Discussing Cessation Strategies", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 43.8, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 429, "Indicator": "Rate", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 10.2, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 430, "Indicator": "Observed/Expected Ratio", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.1646, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 432, "Indicator": "Rate", "state": "Connecticut", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 81, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 11,072. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 434, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.2, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 435, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 47.3, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 436, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 17.4, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 437, "Indicator": "Rate", "state": "Connecticut", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 8.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 438, "Indicator": "Rate", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 64.1, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was audited by HEDIS compliance auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 440, "Indicator": "Rate", "state": "Connecticut", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 78.8, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 446, "Indicator": "Rate", "state": "Delaware", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 80.7, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population. Denominator is the sample size; measure-eligible population is 48,288.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 450, "Indicator": "Acute Phase Treatment", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 451, "Indicator": "Continuation Phase Treatment", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 36.6, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 452, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 45.1, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 453, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 454, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 57.1, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 463, "Indicator": "Rate", "state": "Delaware", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.9, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 40 percent of the population. Rate excludes FFS population and enrollees in 1 MCO, representing 60 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 464, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 53.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population. Denominator is the sample size; measure-eligible population is 12,613. Due to the COVID-19 public health emergency, 1 MCO reported using FFY 2019 data and 1 MCO reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 465, "Indicator": "LARC", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.1, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 466, "Indicator": "LARC", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.7, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 467, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.5, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 468, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.6, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 473, "Indicator": "Rate", "state": "Delaware", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 72.5, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 38,062.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 474, "Indicator": "LARC", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.1, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 475, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.4, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 478, "Indicator": "Rate", "state": "Delaware", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 482, "Indicator": "Rate", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 11.3, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 484, "Indicator": "30-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 17.7, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 485, "Indicator": "7-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 10.4, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 486, "Indicator": "30-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 35.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 487, "Indicator": "7-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.7, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 488, "Indicator": "30-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 40.4, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 489, "Indicator": "7-Day Follow-Up", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 29.4, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 490, "Indicator": "Rate", "state": "Delaware", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 43.3, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 491, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 44.3, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population. Denominator is the sample size; measure-eligible population is 8,653.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 492, "Indicator": "Initiation", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 49.1, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 504, "Indicator": "Discussing Cessation Medications", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 53, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 505, "Indicator": "Discussing Cessation Strategies", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 49.4, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 506, "Indicator": "Rate", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 8.1, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 507, "Indicator": "Observed/Expected Ratio", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.195, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 81 percent of the population. Rates exclude FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 509, "Indicator": "Rate", "state": "Delaware", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 72.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 4,011.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 511, "Indicator": "Rate", "state": "Delaware", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 21.3, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 512, "Indicator": "Rate", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.9, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 513, "Indicator": "Rate", "state": "Delaware", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 75.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 81 percent of the population. Rate excludes FFS population, representing 19 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 519, "Indicator": "Rate", "state": "District of Columbia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 85.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 74, representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. Denominator is the sample size; measure-eligible population is 50,147. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 523, "Indicator": "Acute Phase Treatment", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 46.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 524, "Indicator": "Continuation Phase Treatment", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 30.2, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 525, "Indicator": "Rate", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 526, "Indicator": "Rate", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 527, "Indicator": "Rate", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 56.9, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 536, "Indicator": "Rate", "state": "District of Columbia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 50 to 74, representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 537, "Indicator": "Rate", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 49.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 85, representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. Denominator is the sample size; measure-eligible population is 13,027. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 538, "Indicator": "LARC", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 3.6, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 539, "Indicator": "LARC", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 13.4, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 540, "Indicator": "Most or Moderately Effective Contraceptive", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 13, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 541, "Indicator": "Most or Moderately Effective Contraceptive", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.9, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 546, "Indicator": "Rate", "state": "District of Columbia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 56.6, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. Denominator is the sample size; measure-eligible population is 45,440. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 547, "Indicator": "LARC", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 3.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 548, "Indicator": "Most or Moderately Effective Contraceptive", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.9, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 551, "Indicator": "Rate", "state": "District of Columbia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 79, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 555, "Indicator": "30-Day Follow-Up", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 59.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 556, "Indicator": "7-Day Follow-Up", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 41, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 559, "Indicator": "30-Day Follow-Up", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 32.3, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 560, "Indicator": "7-Day Follow-Up", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 21.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 561, "Indicator": "Rate", "state": "District of Columbia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 40.7, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 562, "Indicator": "Rate", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 43.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 75, representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. Denominator is the sample size; measure-eligible population is 7,258. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 566, "Indicator": "Advising Users to Quit", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 76.6, "number_of_states_reporting": 28, "median": 76.7, "percentile_25th": 73.6, "percentile_75th": 79.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 567, "Indicator": "Discussing Cessation Medications", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 50.9, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 568, "Indicator": "Discussing Cessation Strategies", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 45.6, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 569, "Indicator": "Observed/Expected Ratio", "state": "District of Columbia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.8542, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 78 percent of the population. Rates exclude FFS population, representing 22 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 571, "Indicator": "Rate", "state": "District of Columbia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 74.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. Denominator is the sample size; measure-eligible population is 2,803. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 573, "Indicator": "Rate", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 35.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 575, "Indicator": "Rate", "state": "District of Columbia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 75.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 78 percent of the population. Rate excludes FFS population, representing 22 percent of the population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 581, "Indicator": "Rate", "state": "Florida", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 92.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs) ages 18 to 74, representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and 13 MCOs used the hybrid method. Denominator is the measure-eligible population. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 2 MCOs reported using FFY 2019 data and 12 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 585, "Indicator": "Acute Phase Treatment", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs) age 18 and older, representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 586, "Indicator": "Continuation Phase Treatment", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.7, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs) age 18 and older, representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 587, "Indicator": "Rate", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 588, "Indicator": "Rate", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 589, "Indicator": "Rate", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.7, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 598, "Indicator": "Rate", "state": "Florida", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 60.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (12 MCOs) ages 50 to 74, representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 599, "Indicator": "Rate", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 66.3, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (18 MCOs) ages 18 to 85, representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 99,378. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 4 MCOs reported using FFY 2019 data and 14 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 600, "Indicator": "LARC", "state": "Florida", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.4, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 601, "Indicator": "LARC", "state": "Florida", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 602, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Florida", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.2, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 603, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Florida", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.9, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 608, "Indicator": "Rate", "state": "Florida", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 58.5, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (16 MCOs), representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and 15 MCOs used the hybrid method. Denominator is the measure-eligible population. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 7 MCOs reported using FFY 2019 data and 9 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 611, "Indicator": "Rate", "state": "Florida", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 69.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (17 MCOs), representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 616, "Indicator": "30-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 9.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs) age 18 and older, representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 617, "Indicator": "7-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.5, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs) age 18 and older, representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 618, "Indicator": "30-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.9, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 619, "Indicator": "7-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 622, "Indicator": "30-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 623, "Indicator": "7-Day Follow-Up", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.4, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 624, "Indicator": "Rate", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 42.4, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (18 MCOs) ages 18 to 75, representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and 16 MCOs used the hybrid method. Denominator is the measure-eligible population. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 6 MCOs reported using FFY 2019 data and 12 plans reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 625, "Indicator": "Initiation", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (18 MCOs) age 18 and older, representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 637, "Indicator": "Discussing Cessation Medications", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 54.3, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 638, "Indicator": "Discussing Cessation Strategies", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 54.9, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 639, "Indicator": "", "state": "Florida", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.6, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the iBudget Waiver and CDC+ waiver. Funding sources include HCBS and 1915(j) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 32,421. State stratified by support coordinator to generate the sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 640, "Indicator": "", "state": "Florida", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 74.9, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the iBudget Waiver and CDC+ waiver. Funding sources include HCBS and 1915(j) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 32,421. State stratified by support coordinator to generate the sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 641, "Indicator": "", "state": "Florida", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 84.7, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the iBudget Waiver and CDC+ waiver. Funding sources include HCBS and 1915(j) waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 32,421. State stratified by support coordinator to generate the sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 642, "Indicator": "Observed/Expected Ratio", "state": "Florida", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.1449, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 65 percent of the population. Rates exclude FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 644, "Indicator": "Rate", "state": "Florida", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 73.3, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (17 MCOs), representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 72,007. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 646, "Indicator": "Rate", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 60.2, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (18 MCOs), representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 648, "Indicator": "Rate", "state": "Florida", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (16 MCOs), representing 65 percent of the population. Rate excludes FFS population, representing 35 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 654, "Indicator": "Rate", "state": "Georgia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 87.8, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 51,897. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 658, "Indicator": "Acute Phase Treatment", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.9, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 659, "Indicator": "Continuation Phase Treatment", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.3, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 660, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 661, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 662, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.5, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 671, "Indicator": "Rate", "state": "Georgia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.9, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 672, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 44.8, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 17,059. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 673, "Indicator": "Rate", "state": "Georgia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 67.6, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 674, "Indicator": "Rate", "state": "Georgia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 72, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 677, "Indicator": "30-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 9.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 678, "Indicator": "7-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.7, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 679, "Indicator": "30-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.9, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 6 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 680, "Indicator": "7-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.4, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 6 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 683, "Indicator": "30-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.4, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 684, "Indicator": "7-Day Follow-Up", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 36.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 685, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 57.5, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 8,180. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 686, "Indicator": "Initiation", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": "NR", "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "NR = State did not report the measure for this population.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State was unable to report rates for diagnosis cohorts for FFY 2020. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "No", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 698, "Indicator": "", "state": "Georgia", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 77.3, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the New Options Waiver (NOW) and Comprehensive Supports waiver (COMP), as well as adults in State Funded Services (SFS). Funding sources include HCBS waiver and state funds. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 13,548. State used a two-stage stratified approach to generate the sample. First, half of all active providers were randomly selected for review. Second, from the list of adults receiving services from providers selected for review, the state randomly selected adults by region who did not participate in a review in the previous year. The number of adults selected within each region is proportionate to the number of adults receiving services within the region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 699, "Indicator": "", "state": "Georgia", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 83.4, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the New Options Waiver (NOW) and Comprehensive Supports waiver (COMP), as well as adults in State Funded Services (SFS). Funding sources include HCBS waiver and state funds. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 13,548. State used a two-stage stratified approach to generate the sample. First, half of all active providers were randomly selected for review. Second, from the list of adults receiving services from providers selected for review, the state randomly selected adults by region who did not participate in a review in the previous year. The number of adults selected within each region is proportionate to the number of adults receiving services within the region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 700, "Indicator": "Observed/Expected Ratio", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.8068, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 702, "Indicator": "Rate", "state": "Georgia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 63, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 48,724. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 704, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 14.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 705, "Indicator": "Rate", "state": "Georgia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.4, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 706, "Indicator": "Rate", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate excludes beneficiaries in the foster care and criminal justice systems who are on a specialized mental health managed care plan. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 707, "Indicator": "Rate", "state": "Georgia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 83.2, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 713, "Indicator": "Rate", "state": "Hawaii", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 86.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and four MCOs used the hybrid method. Denominator is the measure-eligible population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 717, "Indicator": "Acute Phase Treatment", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 718, "Indicator": "Continuation Phase Treatment", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 36.3, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 719, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 40.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 720, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 43.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 721, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 49.9, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 726, "Indicator": "Rate", "state": "Hawaii", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 727, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 59.2, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Denominator is the sample size; measure-eligible population is 29,297.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 728, "Indicator": "Rate", "state": "Hawaii", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 62.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and four MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 729, "Indicator": "Rate", "state": "Hawaii", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 55.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 733, "Indicator": "30-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 22.5, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 734, "Indicator": "7-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 735, "Indicator": "30-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 736, "Indicator": "7-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 31.5, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 739, "Indicator": "30-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 42.8, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 740, "Indicator": "7-Day Follow-Up", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 26.1, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 741, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 39.7, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and four MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 742, "Indicator": "Initiation", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 754, "Indicator": "Observed/Expected Ratio", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.9268, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 756, "Indicator": "Rate", "state": "Hawaii", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 65.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Denominator is the sample size; measure-eligible population is 5,645. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 758, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 16.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 759, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 760, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 49.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 761, "Indicator": "Rate", "state": "Hawaii", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 2.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 762, "Indicator": "Rate", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 67.9, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 763, "Indicator": "Rate", "state": "Hawaii", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 73, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 769, "Indicator": "Acute Phase Treatment", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.4, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. State was unable to report Continuation Phase Treatment rate for FFY 2020.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 770, "Indicator": "Continuation Phase Treatment", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": "NR", "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "NR = State did not report the measure for this population.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. State was unable to report Continuation Phase Treatment rate for FFY 2020.", "rate_used_in_calculating": "No", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 771, "Indicator": "Rate", "state": "Idaho", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 772, "Indicator": "Rate", "state": "Idaho", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 32.7, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 773, "Indicator": "Rate", "state": "Idaho", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.9, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 776, "Indicator": "30-Day Follow-Up", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.1, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 777, "Indicator": "7-Day Follow-Up", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 778, "Indicator": "30-Day Follow-Up", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 779, "Indicator": "7-Day Follow-Up", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.2, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 780, "Indicator": "Rate", "state": "Idaho", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 98.1, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 784, "Indicator": "Rate", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 78.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 785, "Indicator": "Rate", "state": "Idaho", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 83.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 786, "Indicator": "Rate", "state": "Illinois", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 32.7, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 790, "Indicator": "Acute Phase Treatment", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 45.8, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 791, "Indicator": "Continuation Phase Treatment", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.4, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 793, "Indicator": "Rate", "state": "Illinois", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 794, "Indicator": "LARC", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 2.6, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 795, "Indicator": "LARC", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 796, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.9, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 797, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.6, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 802, "Indicator": "Rate", "state": "Illinois", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 803, "Indicator": "LARC", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 804, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 22.8, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 807, "Indicator": "Rate", "state": "Illinois", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 60, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 812, "Indicator": "30-Day Follow-Up", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.5, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 813, "Indicator": "7-Day Follow-Up", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 816, "Indicator": "Rate", "state": "Illinois", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 37.9, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 817, "Indicator": "Initiation", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 35.7, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (6 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 829, "Indicator": "Discussing Cessation Medications", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 54.7, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 830, "Indicator": "Discussing Cessation Strategies", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 47, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 831, "Indicator": "", "state": "Illinois", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 89.6, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Adults with Developmental Disabilities Waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 22,073. State generated a random sample of all adults receiving services from the state's Adults with Developmental Disabilities waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 832, "Indicator": "", "state": "Illinois", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 64.1, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Adults with Developmental Disabilities Waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 22,073. State generated a random sample of all adults receiving services from the state's Adults with Developmental Disabilities waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 833, "Indicator": "", "state": "Illinois", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92.4, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Adults with Developmental Disabilities Waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 22,073. State generated a random sample of all adults receiving services from the state's Adults with Developmental Disabilities waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 835, "Indicator": "Rate", "state": "Illinois", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 66.5, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 837, "Indicator": "Rate", "state": "Illinois", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.8, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 838, "Indicator": "Rate", "state": "Illinois", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 62.4, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 839, "Indicator": "Rate", "state": "Illinois", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.8, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 840, "Indicator": "Rate", "state": "Illinois", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 6.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 841, "Indicator": "Rate", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 58.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 842, "Indicator": "Rate", "state": "Illinois", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 85.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (6 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 848, "Indicator": "Rate", "state": "Indiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 85.4, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,410. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 852, "Indicator": "Acute Phase Treatment", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.6, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 853, "Indicator": "Continuation Phase Treatment", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 43, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 862, "Indicator": "Rate", "state": "Indiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.2, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 863, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 54.5, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,443. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 868, "Indicator": "Rate", "state": "Indiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 52.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,466. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 871, "Indicator": "Rate", "state": "Indiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 876, "Indicator": "30-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 20.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 877, "Indicator": "7-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 878, "Indicator": "30-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 879, "Indicator": "7-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.3, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 882, "Indicator": "30-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 883, "Indicator": "7-Day Follow-Up", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.1, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 884, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 55, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 3,042. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 885, "Indicator": "Initiation", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.5, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 897, "Indicator": "", "state": "Indiana", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 86.5, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community Integration and Habilitation (CIH) waiver and Family Supports waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 19,084. State generated the sample by stratifying by waiver and by region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 898, "Indicator": "", "state": "Indiana", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 98, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community Integration and Habilitation (CIH) waiver and Family Supports waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 19,084. State generated the sample by stratifying by waiver and by region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 899, "Indicator": "Observed/Expected Ratio", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.9769, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 901, "Indicator": "Rate", "state": "Indiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 87, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,107. State attributes rate increase to expanded Medicaid coverage for pregnant women during the measurement period. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 903, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 904, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 35.2, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 905, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16.4, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 906, "Indicator": "Rate", "state": "Indiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.8, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 908, "Indicator": "Rate", "state": "Indiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 81.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 914, "Indicator": "Rate", "state": "Iowa", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State did not apply pregnancy exclusion.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 918, "Indicator": "Acute Phase Treatment", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 919, "Indicator": "Continuation Phase Treatment", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 920, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 921, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 922, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 20.6, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 931, "Indicator": "Rate", "state": "Iowa", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.5, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 932, "Indicator": "LARC", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.9, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 933, "Indicator": "LARC", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.6, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 934, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.7, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 935, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 940, "Indicator": "Rate", "state": "Iowa", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.9, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 941, "Indicator": "LARC", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 942, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Iowa", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.5, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 945, "Indicator": "Rate", "state": "Iowa", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 947, "Indicator": "Rate", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 14.7, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 949, "Indicator": "30-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.3, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 950, "Indicator": "7-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.4, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 951, "Indicator": "30-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 952, "Indicator": "7-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 955, "Indicator": "30-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.9, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 956, "Indicator": "7-Day Follow-Up", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 957, "Indicator": "Rate", "state": "Iowa", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 50.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 58 percent of the population. Rate excludes FFS population and enrollees in two MCOs, representing 42 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 958, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 96.3, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 959, "Indicator": "Initiation", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 35.2, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State excluded chemical dependency benefit requirement from calculation of continuous enrollment.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 969, "Indicator": "Discussing Cessation Medications", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 51.2, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (1 MCO), representing 58 percent of the population. Rates exclude FFS population and enrollees in two MCOs, representing 42 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 970, "Indicator": "Discussing Cessation Strategies", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 48.7, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (1 MCO), representing 58 percent of the population. Rates exclude FFS population and enrollees in two MCOs, representing 42 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 971, "Indicator": "Rate", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.7, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 972, "Indicator": "Observed/Expected Ratio", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.9812, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 975, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State used the codes in the Pregnancy Value Set instead of Major Diagnostic Category (MDC) Code Admit = 14 (Pregnancy, Childbirth, and Puerperium). State used codes for transfers from an ambulatory surgical center and transfers from hospice in the Point of Origin field of claims instead of admission source codes for transfers from other hospitals or health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 976, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 96.8, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State used the Pregnancy and Pregnancy Diagnosis Value Sets instead of Major Diagnostic Category (MDC) Code Admit =14 (Pregnancy, Childbirth, and Puerperium). State used codes for transfers from an ambulatory surgical center and transfers from hospice in the Point of Origin claims field instead of admission source codes for transfers from other hospitals or health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 977, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 34.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State used the Pregnancy and Pregnancy Diagnosis Value Sets instead of Major Diagnostic Category (MDC) Code Admit =14 (Pregnancy, Childbirth, and Puerperium). State used codes for transfers from an ambulatory surgical center and transfers from hospice in the Point of Origin claims field instead of admission source codes for transfers from other hospitals or health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 978, "Indicator": "Rate", "state": "Iowa", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.5, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State used the Pregnancy and Pregnancy Diagnosis Value Sets instead of Major Diagnostic Category (MDC) Code Admit =14 (Pregnancy, Childbirth, and Puerperium). State used codes for transfers from an ambulatory surgical center and transfers from hospice in the Point of Origin claims field instead of admission source codes for transfers from other hospitals or health facilities.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 979, "Indicator": "Rate", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 62.5, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. For a small number of beneficiaries who received injections, the state was unable to calculate the proportion of days covered (PDC) and converted 80 percent of PDC to 9 injections and used the entire measurement year as the treatment period for injections.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 981, "Indicator": "Rate", "state": "Iowa", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 76.7, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 984, "Indicator": "Rate", "state": "Kansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 88.8, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs) ages 18 to 74, representing 74 percent of the population. Rate excludes enrollees in one MCO, representing 26 percent of the population. Denominator is the sample size; measure-eligible population is 38,365. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 988, "Indicator": "Acute Phase Treatment", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 989, "Indicator": "Continuation Phase Treatment", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 36, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 990, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 74 percent of the population. Rates exclude enrollees in one MCO, representing 26 percent of the population. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 991, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 74 percent of the population. Rates exclude enrollees in one MCO, representing 26 percent of the population. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 992, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 49.2, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 74 percent of the population. Rates exclude enrollees in one MCO, representing 26 percent of the population. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1001, "Indicator": "Rate", "state": "Kansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs) ages 50 to 74, representing 74 percent of the population. Rate excludes enrollees in one MCO, representing 26 percent of the population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1002, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 54.4, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 85. Denominator is the sample size; measure-eligible population is 19,347. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1003, "Indicator": "LARC", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": "NR", "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "NR = State did not report the measure for this population.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). State was unable to report 3-day postpartum Most or Moderately Effective or LARC rates for FFY 2020.", "rate_used_in_calculating": "No", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1004, "Indicator": "LARC", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.5, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). State was unable to report 3-day postpartum Most or Moderately Effective or LARC rates for FFY 2020.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1005, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": "NR", "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "NR = State did not report the measure for this population.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). State was unable to report 3-day postpartum Most or Moderately Effective or LARC rates for FFY 2020.", "rate_used_in_calculating": "No", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "TRUE" }, { "Obs": 1006, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.5, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). State was unable to report 3-day postpartum Most or Moderately Effective or LARC rates for FFY 2020.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1007, "Indicator": "Rate", "state": "Kansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 57.2, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Denominator is the sample size; measure-eligible population is 41,131. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1008, "Indicator": "LARC", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 6.1, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1009, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 28.7, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1012, "Indicator": "Rate", "state": "Kansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 55.9, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1016, "Indicator": "Rate", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 21.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) age 18 and older.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1018, "Indicator": "30-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 22.2, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1019, "Indicator": "7-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 15.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1020, "Indicator": "30-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 67.4, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1021, "Indicator": "7-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 47.7, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1024, "Indicator": "30-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 71.4, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1025, "Indicator": "7-Day Follow-Up", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 60.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1026, "Indicator": "Rate", "state": "Kansas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 51.9, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1027, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 39, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 75. Denominator is the sample size; measure-eligible population is 13,479. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1028, "Indicator": "Initiation", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 43.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1040, "Indicator": "Discussing Cessation Medications", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 54.5, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs) age 18 and older, representing 76 percent of the population. Rates exclude enrollees in one MCO, representing 24 percent of the population. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1041, "Indicator": "Discussing Cessation Strategies", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 48.1, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs) age 18 and older, representing 76 percent of the population. Rates exclude enrollees in one MCO, representing 24 percent of the population. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1042, "Indicator": "", "state": "Kansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.9, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Intellectual/Developmental Disability program. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 8,200. State generated the sample through proportionate sampling by Community Developmental Disability Organization (CDDO).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1043, "Indicator": "", "state": "Kansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 72.1, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Intellectual/Developmental Disability program. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 8,200. State generated the sample through proportionate sampling by Community Developmental Disability Organization (CDDO).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1044, "Indicator": "", "state": "Kansas", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Intellectual/Developmental Disability program. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the program is 8,200. State generated the sample through proportionate sampling by Community Developmental Disability Organization (CDDO).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1045, "Indicator": "Rate", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 7.7, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) age 18 and older. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1046, "Indicator": "Observed/Expected Ratio", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.9669, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1048, "Indicator": "Rate", "state": "Kansas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 67, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Denominator is the sample size; measure-eligible population is 10,397. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1050, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 25.6, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) age 18 and older.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1051, "Indicator": "Rate", "state": "Kansas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 2.3, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1052, "Indicator": "Rate", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.2, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1054, "Indicator": "Rate", "state": "Kansas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 80.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs). Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1060, "Indicator": "Rate", "state": "Kentucky", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 92, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 74, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. Denominator is the sample size; measure-eligible population is 367,703.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1064, "Indicator": "Acute Phase Treatment", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1065, "Indicator": "Continuation Phase Treatment", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 35, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1066, "Indicator": "Rate", "state": "Kentucky", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1067, "Indicator": "Rate", "state": "Kentucky", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1068, "Indicator": "Rate", "state": "Kentucky", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1077, "Indicator": "Rate", "state": "Kentucky", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 50 to 74, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1078, "Indicator": "Rate", "state": "Kentucky", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 57.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 85, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. Denominator is the sample size; measure-eligible population is 129,757.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1083, "Indicator": "Rate", "state": "Kentucky", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 57.5, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. Denominator is the sample size; measure-eligible population is 271,162.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1086, "Indicator": "Rate", "state": "Kentucky", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 60.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1090, "Indicator": "30-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 31.6, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1091, "Indicator": "7-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1092, "Indicator": "30-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.5, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1093, "Indicator": "7-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 29.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1096, "Indicator": "30-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1097, "Indicator": "7-Day Follow-Up", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 31.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1098, "Indicator": "Initiation", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 43.2, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1110, "Indicator": "", "state": "Kentucky", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 43.2, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Supports for Community Living waiver and Michelle P waiver, as well as adults living in ICF/IID, and adults using state general funds. Funding sources include HCBS waiver and state funds. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 11,136. State used a proportionate sample by program and waiver population. Three regions are under-represented in the data because of interruptions in surveying due to COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1111, "Indicator": "", "state": "Kentucky", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 89.9, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Supports for Community Living waiver and Michelle P waiver, as well as adults living in ICF/IID, and adults using state general funds. Funding sources include HCBS waiver and state funds. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 11,136. State used a proportionate sample by program and waiver population. Three regions are under-represented in the data because of interruptions in surveying due to COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1113, "Indicator": "Rate", "state": "Kentucky", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 68.3, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. Denominator is the sample size; measure-eligible population is 24,393.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1115, "Indicator": "Rate", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.6, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1117, "Indicator": "Rate", "state": "Kentucky", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 84.9, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1123, "Indicator": "Rate", "state": "Louisiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 82.9, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 74, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 362,540. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1127, "Indicator": "Acute Phase Treatment", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 46.8, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1128, "Indicator": "Continuation Phase Treatment", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 31.5, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1129, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1130, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1131, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1140, "Indicator": "Rate", "state": "Louisiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1141, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 50, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 85, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 127,498. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1142, "Indicator": "LARC", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 2.3, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1143, "Indicator": "LARC", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 13.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1144, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.5, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1145, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 50.7, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1150, "Indicator": "Rate", "state": "Louisiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 62.6, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1151, "Indicator": "LARC", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3.9, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1152, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 29.6, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1155, "Indicator": "Rate", "state": "Louisiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 69, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1159, "Indicator": "Rate", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 16.3, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1161, "Indicator": "30-Day Follow-Up", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 34.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1162, "Indicator": "7-Day Follow-Up", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1165, "Indicator": "Rate", "state": "Louisiana", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 42.1, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1166, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 48.5, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 75, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 57,293.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1167, "Indicator": "Initiation", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 48.2, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1179, "Indicator": "Discussing Cessation Medications", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 53.2, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1180, "Indicator": "Discussing Cessation Strategies", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 50.8, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1181, "Indicator": "Rate", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.4, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1182, "Indicator": "Observed/Expected Ratio", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.8705, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1184, "Indicator": "Rate", "state": "Louisiana", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 75.4, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 32,190. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1186, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 19.9, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1187, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.4, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1188, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 31.2, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1189, "Indicator": "Rate", "state": "Louisiana", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3.4, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1190, "Indicator": "Rate", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1192, "Indicator": "Rate", "state": "Louisiana", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 84.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using HEDIS-certified code and state conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1201, "Indicator": "Rate", "state": "Maine", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. State did not apply the anchor date when calculating the measure. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1202, "Indicator": "Rate", "state": "Maine", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. State did not apply the anchor date when calculating the measure. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1203, "Indicator": "Rate", "state": "Maine", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.8, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. State did not apply the anchor date when calculating the measure. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1212, "Indicator": "Rate", "state": "Maine", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 55.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. State did not apply the anchor date when calculating the measure. Rate includes paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1213, "Indicator": "Rate", "state": "Maine", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.4, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. State did not apply the anchor date when calculating the measure. Rate includes paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1216, "Indicator": "Rate", "state": "Maine", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. State did not apply the anchor date when calculating the measure. Rate includes paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1219, "Indicator": "30-Day Follow-Up", "state": "Maine", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 59.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1220, "Indicator": "7-Day Follow-Up", "state": "Maine", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 39.3, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1224, "Indicator": "", "state": "Maine", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 98.2, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in Case Management. Funding source is Medicaid State Plan. Denominator is the number of adults responding to the questions; number of adults included in the program is 5,271. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1225, "Indicator": "", "state": "Maine", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 81.6, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in Case Management. Funding source is Medicaid State Plan. Denominator is the number of adults responding to the questions; number of adults included in the program is 5,271. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1226, "Indicator": "", "state": "Maine", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92.7, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in Case Management. Funding source is Medicaid State Plan. Denominator is the number of adults responding to the questions; number of adults included in the program is 5,271. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1232, "Indicator": "Rate", "state": "Maryland", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 91.5, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 291,580. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1234, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (8 MCOs), representing 84 percent of the population. Rates exclude enrollees in 1 MCO and the FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1235, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (8 MCOs), representing 84 percent of the population. Rates exclude enrollees in 1 MCO and the FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1236, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.2, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (8 MCOs), representing 84 percent of the population. Rates exclude enrollees in 1 MCO and the FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1244, "Indicator": "Rate", "state": "Maryland", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 67.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (8 MCOs), representing 84 percent of the population. Rate excludes enrollees in 1 MCO and the FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1245, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 61, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 87,065. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1246, "Indicator": "Rate", "state": "Maryland", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 62, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 231,503. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1247, "Indicator": "Rate", "state": "Maryland", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 69.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1251, "Indicator": "30-Day Follow-Up", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 33.3, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1252, "Indicator": "7-Day Follow-Up", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 21.9, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1253, "Indicator": "30-Day Follow-Up", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 69.4, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1254, "Indicator": "7-Day Follow-Up", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.5, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1257, "Indicator": "Rate", "state": "Maryland", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 46.6, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1258, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 34.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 44,429. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1259, "Indicator": "Initiation", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 29.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1271, "Indicator": "Discussing Cessation Medications", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 58.4, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1272, "Indicator": "Discussing Cessation Strategies", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 52.3, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1273, "Indicator": "Rate", "state": "Maryland", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 9, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1274, "Indicator": "Observed/Expected Ratio", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.0374, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1276, "Indicator": "Rate", "state": "Maryland", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 81, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 21,910. Rate was audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1278, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 20.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1279, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 61.2, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1280, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 23.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1281, "Indicator": "Rate", "state": "Maryland", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.8, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1287, "Indicator": "Rate", "state": "Massachusetts", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 90.9, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (7 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Denominator is the sample size; measure-eligible population is 79,486. Due to the COVID-19 public health emergency, 4 plans reported using FFY 2019 data and 3 plans reporting using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1291, "Indicator": "Acute Phase Treatment", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 56, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1292, "Indicator": "Continuation Phase Treatment", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 42.2, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1293, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1294, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1295, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1304, "Indicator": "Rate", "state": "Massachusetts", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 69.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1305, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 68.4, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (7 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Denominator is the sample size; measure-eligible population is 28,250. Due to the COVID-19 public health emergency, 5 plans reported using FFY 2019 data and 2 plans used FFY 2020 data. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1306, "Indicator": "LARC", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 2.7, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, ACO, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1307, "Indicator": "LARC", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 17.7, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, ACO, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1308, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.8, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, ACO, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1309, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.9, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, ACO, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1314, "Indicator": "Rate", "state": "Massachusetts", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 70.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (6 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Denominator is the sample size; measure-eligible population is 72,964. Due to the COVID-19 public health emergency, 4 plans reported using FFY 2019 data and 2 plans reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1315, "Indicator": "LARC", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 6.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1316, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.7, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1319, "Indicator": "Rate", "state": "Massachusetts", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 71.6, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1323, "Indicator": "Rate", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.9, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes ACO population (5 MCOs), representing 88 percent of the population. Rate excludes FFS, PCCM, and managed care populations, representing 12 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1325, "Indicator": "30-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 34.7, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1326, "Indicator": "7-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.9, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1327, "Indicator": "30-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 65.5, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates excludes primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1328, "Indicator": "7-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 42.7, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates excludes primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1331, "Indicator": "30-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 80, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1332, "Indicator": "7-Day Follow-Up", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 72.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1333, "Indicator": "Rate", "state": "Massachusetts", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 48.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes Accountable Care Partnership ACO and managed care populations (5 MCOs), representing 74 percent of the population. Rate excludes FFS, primary care ACO, and PCCM populations, representing 26 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey question.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1334, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 35.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Denominator is the sample size; measure-eligible population is 18,228.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1335, "Indicator": "Initiation", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 46, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1347, "Indicator": "Discussing Cessation Medications", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 61, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include Accountable Care Partnership ACO and managed care populations (5 MCOs), representing 74 percent of the population. Rates exclude FFS, primary care ACO, and PCCM populations, representing 26 percent of the population. Rates also exclude Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey questions.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1348, "Indicator": "Discussing Cessation Strategies", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 56.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include Accountable Care Partnership ACO and managed care populations (5 MCOs), representing 74 percent of the population. Rates exclude FFS, primary care ACO, and PCCM populations, representing 26 percent of the population. Rates also exclude Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey questions.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1349, "Indicator": "", "state": "Massachusetts", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92.9, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates primarily include adults in the Intensive Supports waiver, Community Living waiver, and Adults Supports waiver and also include a small number of adults in the Acquired Brain Injury-Residential Habilitation (ABI-RH) and Moving Forward Plan-Residential Supports (MFP-RS) Waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 20,133. State used a proportional sample based on the region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1350, "Indicator": "", "state": "Massachusetts", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 59.4, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates primarily include adults in the Intensive Supports waiver, Community Living waiver, and Adults Supports waiver and also include a small number of adults in the Acquired Brain Injury-Residential Habilitation (ABI-RH) and Moving Forward Plan-Residential Supports (MFP-RS) Waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 20,133. State used a proportional sample based on the region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1351, "Indicator": "", "state": "Massachusetts", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates primarily include adults in the Intensive Supports waiver, Community Living waiver, and Adults Supports waiver and also include a small number of adults in the Acquired Brain Injury-Residential Habilitation (ABI-RH) and Moving Forward Plan-Residential Supports (MFP-RS) Waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 20,133. State used a proportional sample based on the region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1352, "Indicator": "Rate", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes ACO population (5 MCOs), representing 88 percent of the population. Rate excludes FFS, PCCM, and managed care populations, representing 12 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1353, "Indicator": "Observed/Expected Ratio", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1.2086, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rates exclude primary care ACO and FFS populations, representing 20 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1355, "Indicator": "Rate", "state": "Massachusetts", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 77, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (4 MCOs), representing 66 percent of the population. Rate excludes primary care ACO and FFS populations and enrollees in MCOs that could not report for FFY 2020, representing 34 percent of the population. Denominator is the sample size; measure-eligible population is 7,509.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1357, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.9, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, ACO, and managed care populations (3 MCOs). Rate excludes FFS population, but most FFS beneficiaries would not be eligible for the measure, including beneficiaries who have other insurance, reside in a long-term care institution, or receive limited or temporary Medicaid benefits. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1358, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.4, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, ACO, and managed care populations (3 MCOs). Rate excludes FFS population, but most FFS beneficiaries would not be eligible for the measure, including beneficiaries who have other insurance, reside in a long-term care institution, or receive limited or temporary Medicaid benefits. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1359, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.9, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, ACO, and managed care populations (3 MCOs). Rate excludes FFS population, but most FFS beneficiaries would not be eligible for the measure, including beneficiaries who have other insurance, reside in a long-term care institution, or receive limited or temporary Medicaid benefits. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1360, "Indicator": "Rate", "state": "Massachusetts", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, ACO, and managed care populations (3 MCOs). Rate excludes FFS population, but most FFS beneficiaries would not be eligible for the measure, including beneficiaries who have other insurance, reside in a long-term care institution, or receive limited or temporary Medicaid benefits. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1361, "Indicator": "Rate", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 69, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1363, "Indicator": "Rate", "state": "Massachusetts", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 81.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes PCCM, Accountable Care Partnership ACO, and managed care populations (5 MCOs), representing 80 percent of the population. Rate excludes primary care ACO and FFS populations, representing 20 percent of the population. Rate also excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1369, "Indicator": "Rate", "state": "Michigan", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 64.1, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1373, "Indicator": "Acute Phase Treatment", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1374, "Indicator": "Continuation Phase Treatment", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 29.9, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1375, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1376, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1377, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.2, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1382, "Indicator": "Rate", "state": "Michigan", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.5, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1383, "Indicator": "LARC", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.8, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 22 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1384, "Indicator": "LARC", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.5, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 22 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1385, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.2, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 22 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1386, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 30.1, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 22 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1391, "Indicator": "Rate", "state": "Michigan", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.2, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1392, "Indicator": "LARC", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.9, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. Data source is the state's Data Warehouse, which contains MMIS and pharmacy data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1393, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. Data source is the state's Data Warehouse, which contains MMIS and pharmacy data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1396, "Indicator": "Rate", "state": "Michigan", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 68.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1400, "Indicator": "Rate", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1402, "Indicator": "30-Day Follow-Up", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.7, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1403, "Indicator": "7-Day Follow-Up", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.5, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1404, "Indicator": "30-Day Follow-Up", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1405, "Indicator": "7-Day Follow-Up", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1408, "Indicator": "Initiation", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 32.3, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1420, "Indicator": "Observed/Expected Ratio", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.1172, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1422, "Indicator": "Rate", "state": "Michigan", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 66.4, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1424, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.8, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1425, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 73.7, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1426, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 29.2, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1427, "Indicator": "Rate", "state": "Michigan", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.4, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1428, "Indicator": "Rate", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.5, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1429, "Indicator": "Rate", "state": "Michigan", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (10 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1438, "Indicator": "Acute Phase Treatment", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.1, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1439, "Indicator": "Continuation Phase Treatment", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.7, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1440, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 55.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1441, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 56.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1442, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 59.2, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1451, "Indicator": "Rate", "state": "Minnesota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate includes paid claims only. Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1452, "Indicator": "LARC", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.5, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1453, "Indicator": "LARC", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.9, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1454, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 8.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1455, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 36.3, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1460, "Indicator": "Rate", "state": "Minnesota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.2, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate includes paid claims only. Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1461, "Indicator": "LARC", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 7, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1462, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Minnesota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 30.4, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1465, "Indicator": "Rate", "state": "Minnesota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate includes paid claims only. Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1469, "Indicator": "Rate", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 16.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1471, "Indicator": "30-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 27.4, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1472, "Indicator": "7-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 17.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1473, "Indicator": "30-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1474, "Indicator": "7-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 26.3, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1477, "Indicator": "30-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 60.3, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1478, "Indicator": "7-Day Follow-Up", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 43.5, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1479, "Indicator": "Rate", "state": "Minnesota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 47.9, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1480, "Indicator": "Initiation", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 37.9, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates include paid claims only. Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1492, "Indicator": "Discussing Cessation Medications", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 60.8, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates were audited by a certified HEDIS author.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1493, "Indicator": "Discussing Cessation Strategies", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 51.6, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates were audited by a certified HEDIS author.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1494, "Indicator": "Rate", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 7.2, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). State conducted internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1495, "Indicator": "Observed/Expected Ratio", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.9117, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (8 MCOs). Rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1497, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 19.3, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1498, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate was audited a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1499, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.7, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1500, "Indicator": "Rate", "state": "Minnesota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 4.3, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1501, "Indicator": "Rate", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 68.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate includes paid claims only. Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1503, "Indicator": "Rate", "state": "Minnesota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 75, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (8 MCOs). Rate includes paid claims only. Rate was audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1506, "Indicator": "Rate", "state": "Mississippi", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 83.9, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 43 percent of the population. Rate excludes FFS population and enrollees in one MCO, representing 57 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 45,377.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1510, "Indicator": "Acute Phase Treatment", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.6, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1511, "Indicator": "Continuation Phase Treatment", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1512, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1513, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1514, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.8, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1523, "Indicator": "Rate", "state": "Mississippi", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1524, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 46.8, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 26,461.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1525, "Indicator": "LARC", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.7, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1526, "Indicator": "LARC", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.5, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1527, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.2, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1528, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1533, "Indicator": "Rate", "state": "Mississippi", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 58.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 40,951.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1534, "Indicator": "LARC", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.9, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1535, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.8, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1538, "Indicator": "Rate", "state": "Mississippi", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.8, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1542, "Indicator": "Rate", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.4, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1543, "Indicator": "30-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.6, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1544, "Indicator": "7-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1545, "Indicator": "30-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.7, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1546, "Indicator": "7-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.8, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1549, "Indicator": "30-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.4, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1550, "Indicator": "7-Day Follow-Up", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.9, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1551, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 57, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 11,728.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1552, "Indicator": "Initiation", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 43.7, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1564, "Indicator": "Observed/Expected Ratio", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.1777, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1566, "Indicator": "Rate", "state": "Mississippi", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 69.8, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 16,929.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1568, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.3, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 43 percent of the population. Rate excludes FFS population and enrollees in one MCO, representing 57 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1569, "Indicator": "Rate", "state": "Mississippi", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 66.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 43 percent of the population. Rate excludes FFS population and enrollees in one MCO, representing 57 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1570, "Indicator": "Rate", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1571, "Indicator": "Rate", "state": "Mississippi", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 71.9, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1580, "Indicator": "Acute Phase Treatment", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 47.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1581, "Indicator": "Continuation Phase Treatment", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 28.5, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1582, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 68.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1583, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 69.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1584, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 73.1, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1593, "Indicator": "Rate", "state": "Missouri", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 45.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1594, "Indicator": "LARC", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 2.2, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1595, "Indicator": "LARC", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.4, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1596, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.9, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1597, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 45, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1606, "Indicator": "Rate", "state": "Missouri", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 45.3, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1607, "Indicator": "LARC", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3.3, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1608, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 20.5, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1613, "Indicator": "Rate", "state": "Missouri", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 37.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1617, "Indicator": "Rate", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 22.5, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1618, "Indicator": "30-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 33, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1619, "Indicator": "7-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 31.5, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1620, "Indicator": "30-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1621, "Indicator": "7-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.3, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1624, "Indicator": "30-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 51.5, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1625, "Indicator": "7-Day Follow-Up", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 49.5, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1626, "Indicator": "Rate", "state": "Missouri", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 43.4, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population, representing 75 percent of the population. Rate excludes managed care population, representing 25 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1627, "Indicator": "Initiation", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 38.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1639, "Indicator": "Discussing Cessation Medications", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 55.1, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population, representing 75 percent of the population. Rates exclude managed care population, representing 25 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1640, "Indicator": "Discussing Cessation Strategies", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 47.1, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population, representing 75 percent of the population. Rates exclude managed care population, representing 25 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1641, "Indicator": "", "state": "Missouri", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96.7, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in state waivers and programs. Funding sources include HCBS waiver, state plan, and general revenue. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 16,066. State assigned the number of surveys to each strata (region) based upon the number of QASs assigned to each regional office. One region was not able to complete any surveys due to COVID-19 interruption.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1642, "Indicator": "", "state": "Missouri", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 73, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in state waivers and programs. Funding sources include HCBS waiver, state plan, and general revenue. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 16,066. State assigned the number of surveys to each strata (region) based upon the number of QASs assigned to each regional office. One region was not able to complete any surveys due to COVID-19 interruption.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1643, "Indicator": "", "state": "Missouri", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96.8, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in state waivers and programs. Funding sources include HCBS waiver, state plan, and general revenue. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 16,066. State assigned the number of surveys to each strata (region) based upon the number of QASs assigned to each regional office. One region was not able to complete any surveys due to COVID-19 interruption.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1644, "Indicator": "Rate", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 5.7, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1646, "Indicator": "Rate", "state": "Missouri", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 52.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1648, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 38, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1649, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 156.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1650, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 73.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1651, "Indicator": "Rate", "state": "Missouri", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 6.8, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1652, "Indicator": "Rate", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1655, "Indicator": "Rate", "state": "Missouri", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 88.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1663, "Indicator": "Rate", "state": "Nebraska", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 26.3, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1666, "Indicator": "Rate", "state": "Nebraska", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.1, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1667, "Indicator": "Rate", "state": "Nebraska", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 62.4, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1668, "Indicator": "Rate", "state": "Nebraska", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 40.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1672, "Indicator": "Rate", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1673, "Indicator": "30-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 11.5, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1674, "Indicator": "7-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 4.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1675, "Indicator": "30-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 76.3, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1676, "Indicator": "7-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1679, "Indicator": "30-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 63.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1680, "Indicator": "7-Day Follow-Up", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 42, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1684, "Indicator": "", "state": "Nebraska", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92.4, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS Comprehensive waiver and HCBS Adult Day waiver, as well as adults living in ICFs/ID. Funding sources include HCBS waiver and ICF/ID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 4,296. State randomly selected an initial sample and then drew a sample by proportion of the consumer population by service district for the state. Adults surveyed during the 2017-2018 and 2018-2019 cycles were excluded from the sample in 2019-2020.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1685, "Indicator": "", "state": "Nebraska", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 65.4, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS Comprehensive waiver and HCBS Adult Day waiver, as well as adults living in ICFs/ID. Funding sources include HCBS waiver and ICF/ID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 4,296. State randomly selected an initial sample and then drew a sample by proportion of the consumer population by service district for the state. Adults surveyed during the 2017-2018 and 2018-2019 cycles were excluded from the sample in 2019-2020.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1686, "Indicator": "", "state": "Nebraska", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 94.5, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS Comprehensive waiver and HCBS Adult Day waiver, as well as adults living in ICFs/ID. Funding sources include HCBS waiver and ICF/ID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 4,296. State randomly selected an initial sample and then drew a sample by proportion of the consumer population by service district for the state. Adults surveyed during the 2017-2018 and 2018-2019 cycles were excluded from the sample in 2019-2020.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1687, "Indicator": "Rate", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 5.7, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1689, "Indicator": "Rate", "state": "Nebraska", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 68.9, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1710, "Indicator": "Rate", "state": "Nevada", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1711, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 57.1, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 21,922. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1712, "Indicator": "LARC", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.2, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1713, "Indicator": "LARC", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.7, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1714, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.9, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1715, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.4, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1724, "Indicator": "LARC", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.4, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1725, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21.3, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1736, "Indicator": "30-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1737, "Indicator": "7-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1738, "Indicator": "30-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1739, "Indicator": "7-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 32.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1744, "Indicator": "30-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.9, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1745, "Indicator": "7-Day Follow-Up", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.5, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1746, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 46, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 13,359. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1747, "Indicator": "Initiation", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.2, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1761, "Indicator": "", "state": "Nevada", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 71.1, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in state's HCBS waiver for Individuals with Intellectual and Developmental Disabilities. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 2,294. State used a proportionate sample by regional center.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1762, "Indicator": "", "state": "Nevada", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 88.2, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in state's HCBS waiver for Individuals with Intellectual and Developmental Disabilities. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 2,294. State used a proportionate sample by regional center.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1764, "Indicator": "Rate", "state": "Nevada", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 69.6, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 11,361. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1767, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 13.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1768, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 40.8, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1769, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1770, "Indicator": "Rate", "state": "Nevada", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.6, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1771, "Indicator": "Rate", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.8, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1774, "Indicator": "Rate", "state": "Nevada", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1785, "Indicator": "Rate", "state": "New Hampshire", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 87.3, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 12,070. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1789, "Indicator": "Acute Phase Treatment", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 60.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors. State attributes rate increase from FFY 2019 to increased priority on providing these services.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1790, "Indicator": "Continuation Phase Treatment", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.2, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors. State attributes rate increase from FFY 2019 to increased priority on providing these services.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1791, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.1, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1792, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1793, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1802, "Indicator": "Rate", "state": "New Hampshire", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1803, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 61.9, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 4,203. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1804, "Indicator": "LARC", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.1, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1805, "Indicator": "LARC", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16.7, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1806, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.9, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1807, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1812, "Indicator": "Rate", "state": "New Hampshire", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 57.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 16,615. MCO rates were audited by certified HEDIS auditors. Due to the COVID-19 public health emergency, 1 MCO reported using FFY 2019 data and 1 MCO reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1813, "Indicator": "LARC", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.4, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1814, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.6, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1817, "Indicator": "Rate", "state": "New Hampshire", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1821, "Indicator": "Rate", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.6, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1823, "Indicator": "30-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.2, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors. State attributes rate increase from FFY 2019 to increased priority on providing these services.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1824, "Indicator": "7-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors. State attributes rate increase from FFY 2019 to increased priority on providing these services.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1825, "Indicator": "30-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 72.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (2 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1826, "Indicator": "7-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (2 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1829, "Indicator": "30-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 78.7, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1830, "Indicator": "7-Day Follow-Up", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 70.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1831, "Indicator": "Rate", "state": "New Hampshire", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 48, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1832, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 34.9, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,886.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1833, "Indicator": "Initiation", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1845, "Indicator": "Discussing Cessation Medications", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 61, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1846, "Indicator": "Discussing Cessation Strategies", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 56, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1847, "Indicator": "Rate", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.5, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1848, "Indicator": "Observed/Expected Ratio", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.2409, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 94 percent of the population. Rates exclude FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1850, "Indicator": "Rate", "state": "New Hampshire", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 79.2, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,498. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1852, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 20.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (2 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1853, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.2, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (2 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1854, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.8, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (2 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1855, "Indicator": "Rate", "state": "New Hampshire", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.1, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (2 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1856, "Indicator": "Rate", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 76.6, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1858, "Indicator": "Rate", "state": "New Hampshire", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 82.7, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 94 percent of the population. Rate excludes FFS population, representing 6 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1864, "Indicator": "Rate", "state": "New Jersey", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 91.7, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 74, representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 293,443. Due to the COVID-19 public health emergency, 1 MCO reported using FFY 2019 data and 4 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1868, "Indicator": "Acute Phase Treatment", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1869, "Indicator": "Continuation Phase Treatment", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.9, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1870, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1871, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1872, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1880, "Indicator": "Rate", "state": "New Jersey", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 59.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 50 to 74, representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1881, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 55.6, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 85, representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 108,419. Due to the COVID-19 public health emergency, 2 MCOs reported using FFY 2019 data and 3 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1882, "Indicator": "LARC", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.1, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1883, "Indicator": "LARC", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 5.1, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1884, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.6, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1885, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 33, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1890, "Indicator": "Rate", "state": "New Jersey", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 63.7, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 242,533. Due to the COVID-19 public health emergency, 1 MCO reported using FFY 2019 data and 4 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1891, "Indicator": "LARC", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 2.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1892, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 25.7, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1895, "Indicator": "Rate", "state": "New Jersey", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 68.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1900, "Indicator": "30-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 11.1, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1901, "Indicator": "7-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 7.8, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1902, "Indicator": "30-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1903, "Indicator": "7-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 23.8, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1906, "Indicator": "30-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 63.7, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1907, "Indicator": "7-Day Follow-Up", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55.5, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) who receive services from the state's Division of Developmental Disabilities (DDD), are in Managed Long-Term Services and Supports (MLTSS), or are Fully Integrated Dual Eligible Special Needs Plan enrollees. Rates exclude FFS population, Medicare-Medicaid Dual Eligibles, and managed care enrollees who did not receive services from DDD or participate in MLTSS.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1908, "Indicator": "Rate", "state": "New Jersey", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 41, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1909, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 35.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 75, representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 57,435. Due to the COVID-19 public health emergency, 3 MCOs reported using FFY 2019 data and 2 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1913, "Indicator": "Advising Users to Quit", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 76.1, "number_of_states_reporting": 28, "median": 76.7, "percentile_25th": 73.6, "percentile_75th": 79.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1914, "Indicator": "Discussing Cessation Medications", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 51.2, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1915, "Indicator": "Discussing Cessation Strategies", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 46.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1916, "Indicator": "", "state": "New Jersey", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 84.1, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Supports Program and Community Care Program. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the programs is 21,701. State used a proportionate sample by program/waiver type and geographical region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1917, "Indicator": "", "state": "New Jersey", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 43.6, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Supports Program and Community Care Program. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the programs is 21,701. State used a proportionate sample by program/waiver type and geographical region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1918, "Indicator": "", "state": "New Jersey", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.9, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Supports Program and Community Care Program. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the programs is 21,701. State used a proportionate sample by program/waiver type and geographical region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1919, "Indicator": "Observed/Expected Ratio", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.1959, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 92 percent of the population. Rates exclude FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1921, "Indicator": "Rate", "state": "New Jersey", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 76.2, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 22,312.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1923, "Indicator": "Rate", "state": "New Jersey", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 22.2, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1924, "Indicator": "Rate", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 67, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1925, "Indicator": "Rate", "state": "New Jersey", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 82.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 92 percent of the population. Rate excludes FFS population, representing 8 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1931, "Indicator": "Rate", "state": "New Mexico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 84.4, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs) ages 18 to 74, representing 67 percent of the population. Rate excludes FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 100,349. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1935, "Indicator": "Acute Phase Treatment", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.8, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1936, "Indicator": "Continuation Phase Treatment", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.4, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1937, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 67 percent of the population. Rates exclude FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1938, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 67 percent of the population. Rates exclude FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1939, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (2 MCOs), representing 67 percent of the population. Rates exclude FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1945, "Indicator": "Rate", "state": "New Mexico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs) ages 50 to 74, representing 67 percent of the population. Rate excludes FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1946, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 47.9, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 85, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 37,657. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1947, "Indicator": "Rate", "state": "New Mexico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 43.7, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and one MCO used the hybrid method. Denominator is the measure-eligible population. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1948, "Indicator": "Rate", "state": "New Mexico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.1, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (2 MCOs), representing 67 percent of the population. Rate excludes FFS population and enrollees in 1 MCO, representing 33 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1952, "Indicator": "30-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 19.1, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1953, "Indicator": "7-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 12.1, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1954, "Indicator": "30-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 36.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1955, "Indicator": "7-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.1, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1958, "Indicator": "30-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.2, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1959, "Indicator": "7-Day Follow-Up", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.7, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1960, "Indicator": "Rate", "state": "New Mexico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 45, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1961, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 52, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 75, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 30,121. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1962, "Indicator": "Initiation", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1974, "Indicator": "Discussing Cessation Medications", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 42.5, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1975, "Indicator": "Discussing Cessation Strategies", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 47.9, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1976, "Indicator": "Observed/Expected Ratio", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.8137, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1978, "Indicator": "Rate", "state": "New Mexico", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 66.3, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 10,644. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1980, "Indicator": "Rate", "state": "New Mexico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1981, "Indicator": "Rate", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.4, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1982, "Indicator": "Rate", "state": "New Mexico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 78.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by certified HEDIS auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1991, "Indicator": "Acute Phase Treatment", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.1, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (58 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1992, "Indicator": "Continuation Phase Treatment", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.6, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (58 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1993, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (50 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 1994, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (50 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 1995, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.8, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (50 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2004, "Indicator": "Rate", "state": "New York", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (64 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2005, "Indicator": "LARC", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (44 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2006, "Indicator": "LARC", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (44 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2007, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 11.7, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (44 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2008, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 34.3, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (44 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2013, "Indicator": "Rate", "state": "New York", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (63 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2014, "Indicator": "LARC", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.7, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (65 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2015, "Indicator": "Most or Moderately Effective Contraceptive", "state": "New York", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.2, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (65 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2018, "Indicator": "Rate", "state": "New York", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 71.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (42 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2020, "Indicator": "Rate", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 17.9, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (58 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2021, "Indicator": "30-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.8, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (49 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2022, "Indicator": "7-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.4, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (49 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2023, "Indicator": "30-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (54 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2024, "Indicator": "7-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (54 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2025, "Indicator": "30-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 72, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (53 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2026, "Indicator": "7-Day Follow-Up", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.4, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (53 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2027, "Indicator": "Rate", "state": "New York", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 53.1, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (31 MCOs), representing 76 percent of the population. Rate excludes FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2028, "Indicator": "Initiation", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (60 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State conducted an internal validation of the data. State attributes rate increases from FFY 2019 to programs for people living with mental health and substance use disorders, including the Health and Recovery Plan, statewide treatment service programs, and public awareness campaigns.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2038, "Indicator": "Discussing Cessation Medications", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 72.8, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (31 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data. State attributes rate increases from FFY 2019 to statewide tobacco control program and a recent Medicaid campaign to support smoking cessation.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2039, "Indicator": "Discussing Cessation Strategies", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 65.5, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (31 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data. State attributes rate increases from FFY 2019 to statewide tobacco control program and a recent Medicaid campaign to support smoking cessation.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2040, "Indicator": "Observed/Expected Ratio", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.0363, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (31 MCOs), representing 76 percent of the population. Rates exclude FFS population, representing 24 percent of the population, and Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2042, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (71 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2043, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (71 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2044, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 19.4, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (71 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2045, "Indicator": "Rate", "state": "New York", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.2, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (55 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2046, "Indicator": "Rate", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 64.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (64 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2048, "Indicator": "Rate", "state": "New York", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.8, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (60 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. State conducted an internal review of the data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2057, "Indicator": "Acute Phase Treatment", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.2, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2058, "Indicator": "Continuation Phase Treatment", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2059, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2060, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2061, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.1, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2078, "Indicator": "Rate", "state": "North Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2079, "Indicator": "LARC", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.3, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2080, "Indicator": "LARC", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 15.3, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2081, "Indicator": "Most or Moderately Effective Contraceptive", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 15.3, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2082, "Indicator": "Most or Moderately Effective Contraceptive", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.9, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2091, "Indicator": "Rate", "state": "North Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 43.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2092, "Indicator": "LARC", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.3, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2093, "Indicator": "Most or Moderately Effective Contraceptive", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.9, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2098, "Indicator": "Rate", "state": "North Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 63.9, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2105, "Indicator": "Rate", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 14.9, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2108, "Indicator": "30-Day Follow-Up", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2109, "Indicator": "7-Day Follow-Up", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 25.4, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2114, "Indicator": "30-Day Follow-Up", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2115, "Indicator": "7-Day Follow-Up", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2116, "Indicator": "Initiation", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2131, "Indicator": "", "state": "North Carolina", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 65.8, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in developmental centers, Innovations waiver, Medicaid state plan, and 1915(b)(3) services. Funding sources include ICF/ID funding, HBCS waiver, state plan, and 1915(b) waiver. Denominator is the number of adults responding to the questions; number of adults included in the programs is 14,945. State used approximately proportional random sampling by Local Management Entities ' Managed Care Organizations and Developmental Centers of adults age 18 and older who received at least one Medicaid I/DD service in the previous fiscal year.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2132, "Indicator": "", "state": "North Carolina", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 98.6, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in developmental centers, Innovations waiver, Medicaid state plan, and 1915(b)(3) services. Funding sources include ICF/ID funding, HBCS waiver, state plan, and 1915(b) waiver. Denominator is the number of adults responding to the questions; number of adults included in the programs is 14,945. State used approximately proportional random sampling by Local Management Entities ' Managed Care Organizations and Developmental Centers of adults age 18 and older who received at least one Medicaid I/DD service in the previous fiscal year.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2133, "Indicator": "Rate", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.8, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2134, "Indicator": "Observed/Expected Ratio", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.9289, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2136, "Indicator": "Rate", "state": "North Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 68.8, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2137, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.3, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2138, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 92.5, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2139, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2140, "Indicator": "Rate", "state": "North Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 7.7, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2141, "Indicator": "Rate", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 64, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2144, "Indicator": "Rate", "state": "North Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 79.7, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated using NCQA-certified software.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2149, "Indicator": "Rate", "state": "North Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 94, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 5,925. Data sources include MCO claims and audited supplemental EHR data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2153, "Indicator": "Acute Phase Treatment", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.3, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2154, "Indicator": "Continuation Phase Treatment", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2155, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2156, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2157, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.6, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2166, "Indicator": "Rate", "state": "North Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles. Data sources include MCO claims and audited supplemental EHR data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2167, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 70, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,058. Data sources include MCO claims and audited supplemental EHR data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2168, "Indicator": "LARC", "state": "North Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": "NR", "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "NR = State did not report the measure for this population.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations, representing 49 percent of the population. Rates exclude managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "No", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2169, "Indicator": "LARC", "state": "North Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 10.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations, representing 49 percent of the population. Rates exclude managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2170, "Indicator": "Most or Moderately Effective Contraceptive", "state": "North Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations, representing 49 percent of the population. Rates exclude managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2171, "Indicator": "Most or Moderately Effective Contraceptive", "state": "North Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 35.2, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations, representing 49 percent of the population. Rates exclude managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2176, "Indicator": "Rate", "state": "North Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles. Data sources include MCO claims and audited supplemental EHR data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2179, "Indicator": "Rate", "state": "North Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 43.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (1 MCO). Rate excludes Medicare-Medicaid Dual Eligibles. Data sources include MCO claims and audited supplemental lab data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2183, "Indicator": "Rate", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 15.9, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations, representing 49 percent of the population. Rate excludes managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2185, "Indicator": "30-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.4, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles. State used methodology that includes only the first and last ED visit in the measurement period for each beneficiary. For cases where the beneficiary's last visit falls within 31 days of the first visit, only the first visit is included. State estimates that 10 to 50 ED visits were excluded from the analysis as a result of this methodology.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2186, "Indicator": "7-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles. State used methodology that includes only the first and last ED visit in the measurement period for each beneficiary. For cases where the beneficiary's last visit falls within 31 days of the first visit, only the first visit is included. State estimates that 10 to 50 ED visits were excluded from the analysis as a result of this methodology.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2187, "Indicator": "30-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 36, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2188, "Indicator": "7-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2191, "Indicator": "30-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.4, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2192, "Indicator": "7-Day Follow-Up", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.3, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2193, "Indicator": "Rate", "state": "North Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 38.6, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2194, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 28.7, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 1,312. Data sources include MCO claims and audited supplemental EHR and lab data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2195, "Indicator": "Initiation", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.1, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and managed care populations (1 MCO). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2207, "Indicator": "Discussing Cessation Medications", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 52.1, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (1 MCO), representing 51 percent of the population. Rates exclude FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2208, "Indicator": "Discussing Cessation Strategies", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 48.1, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (1 MCO), representing 51 percent of the population. Rates exclude FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2209, "Indicator": "Rate", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.9, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations age 18 and older, representing 49 percent of the population. Rate excludes managed care population, representing 51 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2210, "Indicator": "Observed/Expected Ratio", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.4182, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (1 MCO), representing 51 percent of the population. Rates exclude FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2213, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2214, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 48.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2215, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.1, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2216, "Indicator": "Rate", "state": "North Dakota", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": "DS", "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "DS = Data suppressed because data cannot be displayed per the Centers for Medicare & Medicaid Services' cell-size suppression policy, which prohibits the direct reporting of data for beneficiary and record counts of 1 to 10 and values from which users can derive values of 1 to 10.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (1 MCO), representing 51 percent of the population. Rate excludes FFS and PCCM populations, representing 49 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "No", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "TRUE" }, { "Obs": 2217, "Indicator": "Rate", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 63.1, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (1 MCO). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2219, "Indicator": "Rate", "state": "North Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 77.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and managed care populations (1 MCO). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2222, "Indicator": "Rate", "state": "Ohio", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 86.5, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 74, representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 582,407. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2226, "Indicator": "Acute Phase Treatment", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 52.2, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2227, "Indicator": "Continuation Phase Treatment", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 34.9, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2228, "Indicator": "Rate", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2229, "Indicator": "Rate", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2230, "Indicator": "Rate", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2239, "Indicator": "Rate", "state": "Ohio", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55.3, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 50 to 74, representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2240, "Indicator": "Rate", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 61.1, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 85, representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 186,788. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 1 MCO reported using FFY 2019 data and 4 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2241, "Indicator": "Rate", "state": "Ohio", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 64.9, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 466,187. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 2 MCOs reported using FFY 2019 data and 3 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2242, "Indicator": "Rate", "state": "Ohio", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 66, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2246, "Indicator": "30-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 29.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2247, "Indicator": "7-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 19.1, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2248, "Indicator": "30-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 64.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2249, "Indicator": "7-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.2, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2252, "Indicator": "30-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 55.1, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2253, "Indicator": "7-Day Follow-Up", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 41.4, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2254, "Indicator": "Rate", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 43.9, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 75, representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 97,874. MCO rates were audited by a certified HEDIS auditor. Due to the COVID-19 public health emergency, 2 MCOs reported using FFY 2019 data and 3 MCOs reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2255, "Indicator": "Initiation", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 48.9, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2267, "Indicator": "", "state": "Ohio", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 66, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS waiver and adults living in ICF/IID. Funding sources include HBCS waiver and ICF/IID funding. Survey population is not limited to state Medicaid members; population includes state residents receiving Department of Developmental Disabilities services. Denominator is the number of adults responding to the questions; number of adults included in the population is 42,029. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2268, "Indicator": "", "state": "Ohio", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 97.6, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS waiver and adults living in ICF/IID. Funding sources include HBCS waiver and ICF/IID funding. Survey population is not limited to state Medicaid members; population includes state residents receiving Department of Developmental Disabilities services. Denominator is the number of adults responding to the questions; number of adults included in the population is 42,029. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2269, "Indicator": "Observed/Expected Ratio", "state": "Ohio", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 0.9707, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 84 percent of the population. Rates exclude FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2271, "Indicator": "Rate", "state": "Ohio", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 77.5, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 50,649. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2273, "Indicator": "Rate", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 56.4, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2274, "Indicator": "Rate", "state": "Ohio", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 80.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 84 percent of the population. Rate excludes FFS population, representing 16 percent of the population, and Medicare-Medicaid Dual Eligibles. MCO rates were audited by a certified HEDIS auditor.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2280, "Indicator": "Rate", "state": "Oklahoma", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 31.8, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2284, "Indicator": "Acute Phase Treatment", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 46.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2285, "Indicator": "Continuation Phase Treatment", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 28.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2286, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 68, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2287, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 71.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2288, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 77.3, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2297, "Indicator": "Rate", "state": "Oklahoma", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 39.9, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2298, "Indicator": "LARC", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1.4, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2299, "Indicator": "LARC", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 11.3, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2300, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.3, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2301, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 45.4, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2306, "Indicator": "Rate", "state": "Oklahoma", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.2, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2307, "Indicator": "LARC", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 3.8, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2308, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.2, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2311, "Indicator": "Rate", "state": "Oklahoma", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2315, "Indicator": "Rate", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 22.1, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2317, "Indicator": "30-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 10, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2318, "Indicator": "7-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 6.5, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2319, "Indicator": "30-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2320, "Indicator": "7-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 24.4, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2323, "Indicator": "30-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 44.5, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2324, "Indicator": "7-Day Follow-Up", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 24.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2325, "Indicator": "Rate", "state": "Oklahoma", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 44.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2326, "Indicator": "Initiation", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 32.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and PCCM populations. Rates exclude home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "TRUE" }, { "Obs": 2338, "Indicator": "Discussing Cessation Medications", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": "#", "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "# = Rate not reported because denominator is less than 30.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "No", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2339, "Indicator": "Discussing Cessation Strategies", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": "#", "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "# = Rate not reported because denominator is less than 30.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "No", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2340, "Indicator": "", "state": "Oklahoma", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 86.2, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community waiver, Residential, Community waiver, Non-Residential, Homeward Bound waiver, and In-Home Supports waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,851. State used a proportionate sample by waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2341, "Indicator": "", "state": "Oklahoma", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 69.1, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community waiver, Residential, Community waiver, Non-Residential, Homeward Bound waiver, and In-Home Supports waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,851. State used a proportionate sample by waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2342, "Indicator": "", "state": "Oklahoma", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 98.6, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community waiver, Residential, Community waiver, Non-Residential, Homeward Bound waiver, and In-Home Supports waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 4,851. State used a proportionate sample by waiver.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2343, "Indicator": "Rate", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 4.6, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2344, "Indicator": "Observed/Expected Ratio", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1.1815, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2346, "Indicator": "Rate", "state": "Oklahoma", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 30.1, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees. The majority of the state's providers use global codes for prenatal and postpartum visits and these claims are excluded from the rate because they do not include the information needed to calculate the numerator. As a result, the rate is underestimated.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2348, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 33.3, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2349, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.8, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2350, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.6, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2351, "Indicator": "Rate", "state": "Oklahoma", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 15, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS, PCCM, and waiver populations.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2352, "Indicator": "Rate", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 29.2, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2354, "Indicator": "Rate", "state": "Oklahoma", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 72.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and PCCM populations. Rate excludes home- and community-based services waiver enrollees.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2364, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Electronic Health Records", "state_rate": 72.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs) ages 18 to 85 who are included in electronic health records in the state. Rate excludes FFS population and managed care enrollees who are not included in electronic health record data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2365, "Indicator": "Rate", "state": "Oregon", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 56.2, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2366, "Indicator": "Rate", "state": "Oregon", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2371, "Indicator": "30-Day Follow-Up", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 27.8, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2372, "Indicator": "7-Day Follow-Up", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 17, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2373, "Indicator": "30-Day Follow-Up", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 71.5, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2374, "Indicator": "7-Day Follow-Up", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 59.8, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2375, "Indicator": "Rate", "state": "Oregon", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 37.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2376, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Electronic Health Records", "state_rate": 21.5, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs) ages 18 to 75 who are included in electronic health records in the state. Rate excludes FFS population and managed care enrollees who are not included in electronic health record data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2377, "Indicator": "Initiation", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 36.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2389, "Indicator": "Discussing Cessation Medications", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 54.1, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2390, "Indicator": "Discussing Cessation Strategies", "state": "Oregon", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 47.8, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2391, "Indicator": "", "state": "Oregon", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.4, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the In Home - Direct Services Only, In-Home - Day Supports Only, In Home - Employment Services and Day Support, In Home - Employment Services Only, 24 Hour Residential Services for Adults, Adult Foster Care, Supported Living Services for Adults, and Stabilization and Crisis Unit waivers. Funding source is waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 16,917. State used a proportionate sample by service setting. Data collection was interrupted due to COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2392, "Indicator": "", "state": "Oregon", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 74.8, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the In Home - Direct Services Only, In-Home - Day Supports Only, In Home - Employment Services and Day Support, In Home - Employment Services Only, 24 Hour Residential Services for Adults, Adult Foster Care, Supported Living Services for Adults, and Stabilization and Crisis Unit waivers. Funding source is waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 16,917. State used a proportionate sample by service setting. Data collection was interrupted due to COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2393, "Indicator": "", "state": "Oregon", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96.9, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the In Home - Direct Services Only, In-Home - Day Supports Only, In Home - Employment Services and Day Support, In Home - Employment Services Only, 24 Hour Residential Services for Adults, Adult Foster Care, Supported Living Services for Adults, and Stabilization and Crisis Unit waivers. Funding source is waivers. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 16,917. State used a proportionate sample by service setting. Data collection was interrupted due to COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2394, "Indicator": "Observed/Expected Ratio", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.7666, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (15 CCOs), representing 83 percent of the population. Rates exclude FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2396, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 18.4, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2397, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 29.3, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2398, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.1, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2399, "Indicator": "Rate", "state": "Oregon", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 3.5, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (15 CCOs), representing 83 percent of the population. Rate excludes FFS population, representing 17 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2405, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 95.3, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs) ages 18 to 74. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 555,550. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2409, "Indicator": "Acute Phase Treatment", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.4, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2410, "Indicator": "Continuation Phase Treatment", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2411, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2412, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2413, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.4, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2422, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs) ages 50 to 74. Rate excludes Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2423, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 68.3, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs) ages 18 to 85. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 153,592. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2424, "Indicator": "LARC", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.4, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2425, "Indicator": "LARC", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 12.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2426, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16.8, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2427, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2432, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 64.3, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 445,751. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2433, "Indicator": "LARC", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2434, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 28.6, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2437, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 66.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2441, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.9, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2443, "Indicator": "30-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.3, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2444, "Indicator": "7-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 17.4, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2445, "Indicator": "30-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2446, "Indicator": "7-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 35.9, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2449, "Indicator": "30-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2450, "Indicator": "7-Day Follow-Up", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 39.7, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2451, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 42.3, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2452, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 33.7, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs) ages 18 to 75. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 86,159. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2453, "Indicator": "Initiation", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.9, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2465, "Indicator": "Discussing Cessation Medications", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 34.4, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2466, "Indicator": "Discussing Cessation Strategies", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 28.9, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2467, "Indicator": "", "state": "Pennsylvania", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.2, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Consolidated waiver, Person/Family-Directed Supports (P/FDS) waiver, and Community Living waiver, as well as adults receiving base funding and ICF/IID services. Funding sources include HBCS waiver, state plan, and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 42,000. State used a proportionate sample by county or county/joinder.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2468, "Indicator": "", "state": "Pennsylvania", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 59.5, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Consolidated waiver, Person/Family-Directed Supports (P/FDS) waiver, and Community Living waiver, as well as adults receiving base funding and ICF/IID services. Funding sources include HBCS waiver, state plan, and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 42,000. State used a proportionate sample by county or county/joinder.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2469, "Indicator": "", "state": "Pennsylvania", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 95.3, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Consolidated waiver, Person/Family-Directed Supports (P/FDS) waiver, and Community Living waiver, as well as adults receiving base funding and ICF/IID services. Funding sources include HBCS waiver, state plan, and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and programs is 42,000. State used a proportionate sample by county or county/joinder.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2470, "Indicator": "Observed/Expected Ratio", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.0977, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (9 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2472, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 79.3, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 42,997. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2474, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.6, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Age was determined as of discharge date. State provided MCOs with the following guidelines for calculating the measure: (1) include enrollees enrolled in the MCO at some point during the inpatient stay and continuous enrollment is not required; (2) the enrollment and disenrollment segment that overlaps with the stay and contiguous segments should be linked to show the longest continuous enrollment segment for the enrollee that overlaps with the inpatient stay; and (3) include paid and denied charges, and exclude events that were denied because the enrollee was not a member of the MCO during the stay. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2475, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Age was determined as of discharge date. State provided MCOs with the following guidelines for calculating the measure: (1) include enrollees enrolled in the MCO at some point during the inpatient stay and continuous enrollment is not required; (2) the enrollment and disenrollment segment that overlaps with the stay and contiguous segments should be linked to show the longest continuous enrollment segment for the enrollee that overlaps with the inpatient stay; and (3) include paid and denied charges, and exclude events that were denied because the enrollee was not a member of the MCO during the stay. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2476, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 19.9, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Age was determined as of discharge date. State provided MCOs with the following guidelines for calculating the measure: (1) include enrollees enrolled in the MCO at some point during the inpatient stay and continuous enrollment is not required; (2) the enrollment and disenrollment segment that overlaps with the stay and contiguous segments should be linked to show the longest continuous enrollment segment for the enrollee that overlaps with the inpatient stay; and (3) include paid and denied charges, and exclude events that were denied because the enrollee was not a member of the MCO during the stay. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2477, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.1, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Age was determined as of discharge date. State provided MCOs with the following guidelines for calculating the measure: (1) include enrollees enrolled in the MCO at some point during the inpatient stay and continuous enrollment is not required; (2) the enrollment and disenrollment segment that overlaps with the stay and contiguous segments should be linked to show the longest continuous enrollment segment for the enrollee that overlaps with the inpatient stay; and (3) include paid and denied charges, and exclude events that were denied because the enrollee was not a member of the MCO during the stay. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2478, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 69.3, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2480, "Indicator": "Rate", "state": "Pennsylvania", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 88.1, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (9 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Data were submitted by MCOs and compiled by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2486, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 41, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2491, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 67.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2492, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2493, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2495, "Indicator": "30-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 21.5, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2496, "Indicator": "7-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 16.3, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2497, "Indicator": "30-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 81.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2498, "Indicator": "7-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 63.1, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2499, "Indicator": "30-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 60.7, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2500, "Indicator": "7-Day Follow-Up", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2504, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 20.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2506, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 7.8, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2507, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2508, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 21.5, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2509, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 64.9, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2510, "Indicator": "Rate", "state": "Puerto Rico", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 66.6, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2516, "Indicator": "Rate", "state": "Rhode Island", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 95.4, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 74, representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 76,958.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2520, "Indicator": "Acute Phase Treatment", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 58.9, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2521, "Indicator": "Continuation Phase Treatment", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 44, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2522, "Indicator": "Rate", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2523, "Indicator": "Rate", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2524, "Indicator": "Rate", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2530, "Indicator": "Rate", "state": "Rhode Island", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 65, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 50 to 74, representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2531, "Indicator": "Rate", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 70.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 85, representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 22,950.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2532, "Indicator": "Rate", "state": "Rhode Island", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 59.6, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 53,562.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2533, "Indicator": "Rate", "state": "Rhode Island", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 68.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2537, "Indicator": "30-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 23.8, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2538, "Indicator": "7-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 12.7, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2539, "Indicator": "30-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 71.7, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2540, "Indicator": "7-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 57.2, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2543, "Indicator": "30-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 74.8, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2544, "Indicator": "7-Day Follow-Up", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 64.6, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2545, "Indicator": "Rate", "state": "Rhode Island", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 54, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2546, "Indicator": "Rate", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 33.2, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs) ages 18 to 75, representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 12,209.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2547, "Indicator": "Initiation", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 43.5, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2559, "Indicator": "Discussing Cessation Medications", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 67, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2560, "Indicator": "Discussing Cessation Strategies", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 59.9, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs) age 18 and older, representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2561, "Indicator": "", "state": "Rhode Island", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 84.9, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS waiver. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 3,600. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2562, "Indicator": "", "state": "Rhode Island", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 61.2, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS waiver. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 3,600. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2563, "Indicator": "", "state": "Rhode Island", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 95, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the HCBS waiver. Funding source is 1915(c) waiver. Denominator is the number of adults responding to the questions; number of adults included in the waiver is 3,600. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2564, "Indicator": "Observed/Expected Ratio", "state": "Rhode Island", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.1346, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 87 percent of the population. Rates exclude FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2566, "Indicator": "Rate", "state": "Rhode Island", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 78.8, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 3,999.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2568, "Indicator": "Rate", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 75.6, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2570, "Indicator": "Rate", "state": "Rhode Island", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 79.5, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 87 percent of the population. Rate excludes FFS population, representing 13 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2576, "Indicator": "Rate", "state": "South Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 54.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2580, "Indicator": "Acute Phase Treatment", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 44.7, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2581, "Indicator": "Continuation Phase Treatment", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 28.8, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2582, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2583, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2584, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 49.9, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2593, "Indicator": "Rate", "state": "South Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 58.6, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2594, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 13.6, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2595, "Indicator": "LARC", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 6.8, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2596, "Indicator": "LARC", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.1, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2597, "Indicator": "Most or Moderately Effective Contraceptive", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 20.6, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2598, "Indicator": "Most or Moderately Effective Contraceptive", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 50.8, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2603, "Indicator": "Rate", "state": "South Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 64.9, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 99,573.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2604, "Indicator": "LARC", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 5.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increase from FFY 2019 to a state birth outcomes initiative focused on improving access to contraceptives.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2605, "Indicator": "Most or Moderately Effective Contraceptive", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 36.8, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include family planning waiver and managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increase from FFY 2019 to a state birth outcomes initiative focused on improving access to contraceptives.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2608, "Indicator": "Rate", "state": "South Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 66.3, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2612, "Indicator": "Rate", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 16.8, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2614, "Indicator": "30-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.9, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2615, "Indicator": "7-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 10.9, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2616, "Indicator": "30-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 53.8, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2617, "Indicator": "7-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 30.2, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2620, "Indicator": "30-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 61.3, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2621, "Indicator": "7-Day Follow-Up", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 44.3, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2622, "Indicator": "Rate", "state": "South Carolina", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 42.7, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2623, "Indicator": "Initiation", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 40, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2635, "Indicator": "Discussing Cessation Medications", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 56.5, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2636, "Indicator": "Discussing Cessation Strategies", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "CAHPS 5.0H", "state_rate": 49.5, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2637, "Indicator": "Rate", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 4.1, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2638, "Indicator": "Observed/Expected Ratio", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.1513, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2640, "Indicator": "Rate", "state": "South Carolina", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 91.6, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 23,194.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2642, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 26.8, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2643, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 85.2, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2644, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 31.9, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2645, "Indicator": "Rate", "state": "South Carolina", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3.9, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2646, "Indicator": "Rate", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 66.4, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2648, "Indicator": "Rate", "state": "South Carolina", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 77.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2654, "Indicator": "Rate", "state": "South Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 27.6, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2657, "Indicator": "LARC", "state": "South Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 2.3, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2658, "Indicator": "LARC", "state": "South Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 15.9, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2659, "Indicator": "Most or Moderately Effective Contraceptive", "state": "South Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 14.7, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2660, "Indicator": "Most or Moderately Effective Contraceptive", "state": "South Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 45.6, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2665, "Indicator": "Rate", "state": "South Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 30.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2668, "Indicator": "30-Day Follow-Up", "state": "South Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.9, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2669, "Indicator": "7-Day Follow-Up", "state": "South Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 31.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2672, "Indicator": "Rate", "state": "South Dakota", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 51.5, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2673, "Indicator": "Initiation", "state": "South Dakota", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 39.7, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population. Rates exclude services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nOpioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2686, "Indicator": "Rate", "state": "South Dakota", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 32.6, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population. Rate excludes services provided by the Indian Health Service and may not capture all services reimbursed on a per diem basis, such as those provided by rural health clinics and federally qualified health centers. State attributes lower rate to the use of global codes for pregnancy-related services.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2691, "Indicator": "Rate", "state": "Tennessee", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 94.1, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 74, representing 10 health plans. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 305,238. Rate was validated by the state's EQRO. Due to the COVID-19 public health emergency, 6 health plans reported using FFY 2019 data and 4 health plans reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2698, "Indicator": "Acute Phase Treatment", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2699, "Indicator": "Continuation Phase Treatment", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2700, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2701, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2702, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.9, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2719, "Indicator": "Rate", "state": "Tennessee", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.8, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 50 to 74. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2720, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 64.3, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 85. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 99,476. Rate was validated by the state's EQRO. Due to the COVID-19 public health emergency, state reported using FFY 2019 data.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2721, "Indicator": "LARC", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 2.2, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2722, "Indicator": "LARC", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 12.7, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2723, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 13.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2724, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2733, "Indicator": "Rate", "state": "Tennessee", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 64.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 10 health plans. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 346,059. Rate was validated by the state's EQRO. Due to the COVID-19 public health emergency, 6 health plans reported using FFY 2019 data and 4 health plans reported using FFY 2020 data.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2734, "Indicator": "LARC", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.4, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2735, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.1, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2740, "Indicator": "Rate", "state": "Tennessee", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2747, "Indicator": "Rate", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 9.4, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2748, "Indicator": "30-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.2, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2749, "Indicator": "7-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2750, "Indicator": "30-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55.4, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2751, "Indicator": "7-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 33.5, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2756, "Indicator": "30-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.1, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2757, "Indicator": "7-Day Follow-Up", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 34.9, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2758, "Indicator": "Rate", "state": "Tennessee", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 44.7, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2759, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 37.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 75, representing 10 health plans. Due to the COVID-19 public health emergency, 7 health plans reported using FFY 2019 data and 3 health plans reported using FFY 2020 data. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 49,712. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2760, "Indicator": "Initiation", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 47.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2774, "Indicator": "Discussing Cessation Medications", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 49.8, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2775, "Indicator": "Discussing Cessation Strategies", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 44.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2776, "Indicator": "", "state": "Tennessee", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92.9, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Statewide waiver, Comprehensive Aggregate CAP waiver, and Self-Determination waiver, as well as adults living in ICFs/IID. Funding sources include HCBS waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 7,298. State used a proportionate sample by region. State data excludes managed care population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2777, "Indicator": "", "state": "Tennessee", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 78.9, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Statewide waiver, Comprehensive Aggregate CAP waiver, and Self-Determination waiver, as well as adults living in ICFs/IID. Funding sources include HCBS waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 7,298. State used a proportionate sample by region. State data excludes managed care population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2778, "Indicator": "", "state": "Tennessee", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 98, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Statewide waiver, Comprehensive Aggregate CAP waiver, and Self-Determination waiver, as well as adults living in ICFs/IID. Funding sources include HCBS waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 7,298. State used a proportionate sample by region. State data excludes managed care population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2779, "Indicator": "Rate", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.2, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2780, "Indicator": "Observed/Expected Ratio", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.0737, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2782, "Indicator": "Rate", "state": "Tennessee", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 70.2, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 10 health plans. Due to the COVID-19 public health emergency, 1 health plan reported using FFY 2019 data and 9 health plans reported using FFY 2020 data. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 33,236. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2785, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 17.4, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2786, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 74.9, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2787, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.7, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2788, "Indicator": "Rate", "state": "Tennessee", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2789, "Indicator": "Rate", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.1, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2792, "Indicator": "Rate", "state": "Tennessee", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 85, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2803, "Indicator": "Rate", "state": "Texas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 79, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs) ages 18 to 74. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Rates for the state's FFS population and 12 MCOs were calculated using the administrative method. Five MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2810, "Indicator": "Acute Phase Treatment", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.2, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2811, "Indicator": "Continuation Phase Treatment", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2812, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2813, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2814, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2831, "Indicator": "Rate", "state": "Texas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.4, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs) ages 50 to 74. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2832, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 49.6, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (17 MCOs) ages 18 to 85, representing 88 percent of the population. Rate excludes FFS population, representing 12 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 80,465. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2833, "Indicator": "LARC", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.7, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2834, "Indicator": "LARC", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 14.9, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2835, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 12.4, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2836, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2845, "Indicator": "Rate", "state": "Texas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 53.4, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was calculated using a combination of administrative and hybrid method data. Rates for the state's FFS population and 12 MCOs were calculated using the administrative method. Five MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2846, "Indicator": "LARC", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.1, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2847, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 25.3, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2852, "Indicator": "Rate", "state": "Texas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 61.7, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2859, "Indicator": "Rate", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 21.7, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2862, "Indicator": "30-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.8, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2863, "Indicator": "7-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.9, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2864, "Indicator": "30-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 40.9, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2865, "Indicator": "7-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 22.4, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2870, "Indicator": "30-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 43.9, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2871, "Indicator": "7-Day Follow-Up", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 29.7, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2872, "Indicator": "Rate", "state": "Texas", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 31.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (18 MCOs), representing 88 percent of the population. Rate excludes FFS population, representing 12 percent of the population, and Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey question. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2873, "Indicator": "Initiation", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.6, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs) age 18 and older. Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2888, "Indicator": "Discussing Cessation Medications", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 38.8, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (17 MCOs), representing 88 percent of the population. Rates exclude FFS population, representing 12 percent of the population, and Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey questions. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2889, "Indicator": "Discussing Cessation Strategies", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 35.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (17 MCOs), representing 88 percent of the population. Rates exclude FFS population, representing 12 percent of the population, and Medicare-Medicaid Dual Eligibles. State did not report the number of beneficiaries that responded to the survey questions. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2890, "Indicator": "Observed/Expected Ratio", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.1325, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (18 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2892, "Indicator": "Rate", "state": "Texas", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 78.1, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Rates for the state's FFS population and two MCOs were calculated using the administrative method. Sixteen MCOs used the hybrid method. Denominator is the measure-eligible population. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2893, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 32.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs) age 18 and older. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2894, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 136.3, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs) age 40 and older. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2895, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 101.1, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs) age 18 and older. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2896, "Indicator": "Rate", "state": "Texas", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 4.7, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (17 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2897, "Indicator": "Rate", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.6, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2900, "Indicator": "Rate", "state": "Texas", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 82.5, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (18 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2911, "Indicator": "Rate", "state": "Utah", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative & Hybrid", "state_rate": 92.3, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 74, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. Rate was derived using both administrative and hybrid method data. One MCO used the administrative method and three MCOs used the hybrid method. Denominator is the measure-eligible population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2918, "Indicator": "Acute Phase Treatment", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 50, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2919, "Indicator": "Continuation Phase Treatment", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 35, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs) age 18 and older, representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2920, "Indicator": "Rate", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 60.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2921, "Indicator": "Rate", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2922, "Indicator": "Rate", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.4, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2933, "Indicator": "Rate", "state": "Utah", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 47.2, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 50 to 74, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2934, "Indicator": "Rate", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 73.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 85, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. Denominator is the sample size; measure-eligible population is 6,201. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2935, "Indicator": "Rate", "state": "Utah", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 54.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. Denominator is the sample size; measure-eligible population is 17,937. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2936, "Indicator": "Rate", "state": "Utah", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 48.1, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2943, "Indicator": "30-Day Follow-Up", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 68.7, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2944, "Indicator": "7-Day Follow-Up", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (10 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2949, "Indicator": "Rate", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 29.4, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs) ages 18 to 75, representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. Denominator is the sample size; measure-eligible population is 4,299. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2955, "Indicator": "", "state": "Utah", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 93.8, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community Supports waiver and Acquired Brain Injury waiver, as well as adults from the State Developmental Center. Funding source is waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 5,300. State used a proportionate sample by waiver compared to ICF/IID funding.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2956, "Indicator": "", "state": "Utah", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 68.6, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community Supports waiver and Acquired Brain Injury waiver, as well as adults from the State Developmental Center. Funding source is waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 5,300. State used a proportionate sample by waiver compared to ICF/IID funding.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2957, "Indicator": "", "state": "Utah", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 90, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Community Supports waiver and Acquired Brain Injury waiver, as well as adults from the State Developmental Center. Funding source is waiver and ICF/IID funding. Denominator is the number of adults responding to the questions; number of adults included in the waivers and program is 5,300. State used a proportionate sample by waiver compared to ICF/IID funding.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2958, "Indicator": "Observed/Expected Ratio", "state": "Utah", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.8988, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (4 MCOs), representing 73 percent of the population. Rates exclude FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2960, "Indicator": "Rate", "state": "Utah", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Hybrid", "state_rate": 76.7, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. Denominator is the sample size; measure-eligible population is 6,753. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2963, "Indicator": "Rate", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 66.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 42 percent of the population. Rate excludes FFS population and enrollees in one MCO, representing 58 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2964, "Indicator": "Rate", "state": "Utah", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 88.8, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (4 MCOs), representing 73 percent of the population. Rate excludes FFS population, representing 27 percent of the population. MCO rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2975, "Indicator": "Rate", "state": "Vermont", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 65.9, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan ages 18 to 74, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 52,353.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2979, "Indicator": "Acute Phase Treatment", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 73, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2980, "Indicator": "Continuation Phase Treatment", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 58.4, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2981, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 47.7, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2982, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 50.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2983, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 61.6, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2992, "Indicator": "Rate", "state": "Vermont", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 52.5, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2993, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 52.6, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan ages 18 to 85, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 11,421. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2994, "Indicator": "LARC", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 3, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2995, "Indicator": "LARC", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 18.2, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 2996, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 11.6, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 2997, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 34, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3002, "Indicator": "Rate", "state": "Vermont", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 56, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3003, "Indicator": "LARC", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 8.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3004, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 17.7, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3007, "Indicator": "Rate", "state": "Vermont", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 60.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3011, "Indicator": "Rate", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.2, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3013, "Indicator": "30-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 36.6, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increases from FFY 2019 to peer recovery support in EDs and hospital implementation of rapid access to medication (RAM) for opioid use disorder. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3014, "Indicator": "7-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 24.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increases from FFY 2019 to peer recovery support in EDs and hospital implementation of rapid access to medication (RAM) for opioid use disorder. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3015, "Indicator": "30-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 71.7, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Data sources are MMIS and encounter records from Department of Mental Health database. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3016, "Indicator": "7-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 52.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Data sources are MMIS and encounter records from Department of Mental Health database. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3019, "Indicator": "30-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 75.6, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increases from FFY 2019 to peer recovery support in EDs. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3020, "Indicator": "7-Day Follow-Up", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 67.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles. State attributes rate increases from FFY 2019 to peer recovery support in EDs. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3021, "Indicator": "Rate", "state": "Vermont", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 46.9, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3022, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 47.8, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan ages 18 to 75, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 6,753.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3023, "Indicator": "Initiation", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 40.5, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles. State modified measure to reflect that state Medicaid agency pays for substance abuse treatment services as a monthly unit of bundled treatment services. Rates include residential substance abuse treatment as initiation or engagement events where appropriate following the specifications for sub-acute inpatient care. When the residential substance abuse treatment is the index, both index and initiation dates are set as the last day of residential substance abuse treatment. If there is no gap in services, the next month is counted as engagement. State attributes rate increase from FFY 2019 to implementation of rapid access to medication (RAM) for opioid use disorder. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3035, "Indicator": "Discussing Cessation Medications", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 58.3, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan age 18 and older.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3036, "Indicator": "Discussing Cessation Strategies", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 52.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan age 18 and older.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3037, "Indicator": "Rate", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15.4, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3038, "Indicator": "Observed/Expected Ratio", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 1.0027, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3040, "Indicator": "Rate", "state": "Vermont", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Hybrid", "state_rate": 65.4, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 2,088. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3042, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 13.9, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3043, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 70.7, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3044, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 15, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3045, "Indicator": "Rate", "state": "Vermont", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 4.9, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3046, "Indicator": "Rate", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 80.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3048, "Indicator": "Rate", "state": "Vermont", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP", "methodology": "Administrative", "state_rate": 73, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes statewide 1115 waiver population enrolled in a public non-risk prepaid inpatient health plan, representing the total Medicaid population. Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3054, "Indicator": "Rate", "state": "Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 84.2, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs) ages 18 to 74, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3057, "Indicator": "Acute Phase Treatment", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 57.4, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3058, "Indicator": "Continuation Phase Treatment", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 44.2, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3059, "Indicator": "Rate", "state": "Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3060, "Indicator": "Rate", "state": "Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 64.5, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3061, "Indicator": "Rate", "state": "Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 53.7, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3070, "Indicator": "Rate", "state": "Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 49, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs) ages 50 to 74, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3071, "Indicator": "Rate", "state": "Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 52.8, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs) ages 18 to 85, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3072, "Indicator": "Rate", "state": "Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 46, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3073, "Indicator": "Rate", "state": "Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 61.2, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3077, "Indicator": "30-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 19.1, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3078, "Indicator": "7-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3079, "Indicator": "30-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3080, "Indicator": "7-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 27.6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3083, "Indicator": "30-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 54.7, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3084, "Indicator": "7-Day Follow-Up", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 39.2, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs), representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3085, "Indicator": "Rate", "state": "Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 47.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3086, "Indicator": "Rate", "state": "Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 47.3, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs) ages 18 to 75, representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3087, "Indicator": "Initiation", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 43.1, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available. State attributes higher rates in part to the inclusion of the measure in value-based payment arrangements.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3099, "Indicator": "Discussing Cessation Medications", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 55.4, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3100, "Indicator": "Discussing Cessation Strategies", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "CAHPS 5.0H", "state_rate": 47.2, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (6 MCOs) age 18 and older, representing 90 percent of the population. Rates exclude FFS population, representing 10 percent of the population. State obtained rates from the NCQA Quality Compass and denominators are not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3101, "Indicator": "", "state": "Virginia", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 89.6, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Building Independence waiver, Family and Individual Supports waiver, and Community Living waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 13,589. State used a proportionate sample by health planning region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3102, "Indicator": "", "state": "Virginia", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 61.2, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Building Independence waiver, Family and Individual Supports waiver, and Community Living waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 13,589. State used a proportionate sample by health planning region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3103, "Indicator": "", "state": "Virginia", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96.1, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Building Independence waiver, Family and Individual Supports waiver, and Community Living waiver. Funding source is HBCS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 13,589. State used a proportionate sample by health planning region.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3105, "Indicator": "Rate", "state": "Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Hybrid", "state_rate": 61.8, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3107, "Indicator": "Rate", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 62.7, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3109, "Indicator": "Rate", "state": "Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & CHIP & Dual Eligibles", "methodology": "Administrative", "state_rate": 82.3, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (6 MCOs), representing 90 percent of the population. Rate excludes FFS population, representing 10 percent of the population. State obtained rate from the NCQA Quality Compass and denominator is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3115, "Indicator": "Rate", "state": "Washington", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 91.5, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 74, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 323,226. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3119, "Indicator": "Acute Phase Treatment", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3120, "Indicator": "Continuation Phase Treatment", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.4, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs) age 18 and older, representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3121, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3122, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.2, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3123, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 54.5, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3132, "Indicator": "Rate", "state": "Washington", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 52, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 50 to 74, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3133, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 64.7, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 85, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 64,880. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3134, "Indicator": "LARC", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify specific contraceptive methods and did not use the ICD-10-CM codes added for FFY 2020 to identify births.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3135, "Indicator": "LARC", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify specific contraceptive methods and did not use the ICD-10-CM codes added for FFY 2020 to identify births.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3136, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.7, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify specific contraceptive methods and did not use the ICD-10-CM codes added for FFY 2020 to identify births.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3137, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 40.4, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify specific contraceptive methods and did not use the ICD-10-CM codes added for FFY 2020 to identify births.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3142, "Indicator": "Rate", "state": "Washington", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 60.5, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 251,722. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3143, "Indicator": "LARC", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 6.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify the applicable NDCs for specific contraceptive methods.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3144, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 27.5, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. State used Generic Product Identifier (GPI) codes instead of National Drug Codes (NDCs) to identify the applicable NDCs for specific contraceptive methods.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3147, "Indicator": "Rate", "state": "Washington", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 59.5, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3151, "Indicator": "Rate", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 12.4, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3152, "Indicator": "30-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 30.1, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3153, "Indicator": "7-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 20.3, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3154, "Indicator": "30-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.6, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3155, "Indicator": "7-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 46.1, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3158, "Indicator": "30-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 64.8, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3159, "Indicator": "7-Day Follow-Up", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 53, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3160, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 34.5, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs) ages 18 to 75, representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 42,949. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3161, "Indicator": "Initiation", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 30.8, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3173, "Indicator": "Discussing Cessation Medications", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 50.2, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3174, "Indicator": "Discussing Cessation Strategies", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 46.5, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (5 MCOs), representing 95 percent of the population. Rates exclude FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3175, "Indicator": "Rate", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 8.3, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3176, "Indicator": "Observed/Expected Ratio", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 0.8429, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (5 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3178, "Indicator": "Rate", "state": "Washington", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 73.6, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 24,486. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3180, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 18.1, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3181, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 31.6, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3182, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 24.4, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3183, "Indicator": "Rate", "state": "Washington", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 5.4, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (5 MCOs). Rate excludes Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3184, "Indicator": "Rate", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 65.5, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3186, "Indicator": "Rate", "state": "Washington", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 80.9, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (5 MCOs), representing 95 percent of the population. Rate excludes FFS population, representing 5 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3192, "Indicator": "Rate", "state": "West Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 93.4, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 85,736.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3199, "Indicator": "Acute Phase Treatment", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.4, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3200, "Indicator": "Continuation Phase Treatment", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 41.1, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3201, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.6, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3202, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 57.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3203, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 56.9, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3220, "Indicator": "Rate", "state": "West Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3221, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 66.4, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 32,977. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3222, "Indicator": "LARC", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.7, "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. For women with more than one delivery during the measurement year, rates include only the first live birth.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3223, "Indicator": "LARC", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 9.3, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. For women with more than one delivery during the measurement year, rates include only the first live birth.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3224, "Indicator": "Most or Moderately Effective Contraceptive", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16.1, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. For women with more than one delivery during the measurement year, rates include only the first live birth.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3225, "Indicator": "Most or Moderately Effective Contraceptive", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 45.5, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. For women with more than one delivery during the measurement year, rates include only the first live birth.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3234, "Indicator": "Rate", "state": "West Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 56.7, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 70,970.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3235, "Indicator": "LARC", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 3.6, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3236, "Indicator": "Most or Moderately Effective Contraceptive", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 23.8, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates exclude Medicare-Medicaid Dual Eligibles. Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3241, "Indicator": "Rate", "state": "West Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 51.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate was audited by HEDIS-certified auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3248, "Indicator": "Rate", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": "DS", "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "DS = Data suppressed because data cannot be displayed per the Centers for Medicare & Medicaid Services' cell-size suppression policy, which prohibits the direct reporting of data for beneficiary and record counts of 1 to 10 and values from which users can derive values of 1 to 10.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "No", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "TRUE" }, { "Obs": 3251, "Indicator": "30-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 37.5, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates were audited by HEDIS-certified auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3252, "Indicator": "7-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 29.2, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates were audited by HEDIS-certified auditors.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3253, "Indicator": "30-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.1, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3254, "Indicator": "7-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 16.2, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3259, "Indicator": "30-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 14.8, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3260, "Indicator": "7-Day Follow-Up", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 4.1, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates include paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3261, "Indicator": "Rate", "state": "West Virginia", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Flu Vaccinations for Adults Ages 18 to 64", "measure_abbreviation": "FVA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who Received an Influenza Vaccination: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 36.8, "number_of_states_reporting": 28, "median": 44.8, "percentile_25th": 40.9, "percentile_75th": 48, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Influenza (flu) is a highly contagious respiratory disease that can result in serious illness, hospitalization, and even death. Flu vaccination can prevent infections and reduce medical visits, hospitalizations, and deaths. In particular, flu vaccination is an important preventive tool for people with chronic health conditions who are at high risk for flu complications. The Centers for Disease Control and Prevention (CDC) recommends an annual flu vaccine for everyone six months and older.
\nExplore the percentage of adults ages 18 to 64 who received a flu vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who Received an Influenza Vaccination: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3262, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 37.2, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 15,885.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3263, "Indicator": "Initiation", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 33.3, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). State defined the intake period as the beginning of the measurement year through 47 days prior to the end of the measurement year.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nSmoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Current Smokers and Tobacco Users Advised to Quit: Ages 18 to 64 Years", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3278, "Indicator": "Discussing Cessation Medications", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 49.9, "number_of_states_reporting": 28, "median": 53.7, "percentile_25th": 50.6, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Medications: Ages 18 to 64 Years", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3279, "Indicator": "Discussing Cessation Strategies", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Medical Assistance With Smoking and Tobacco Use Cessation: Age 18 and older", "measure_abbreviation": "MSC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "ffy": 2020, "population": "Medicaid", "methodology": "CAHPS 5.0H", "state_rate": 44.9, "number_of_states_reporting": 28, "median": 48, "percentile_25th": 45.9, "percentile_75th": 51.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (3 MCOs), representing 79 percent of the population. Rates exclude FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Smoking and tobacco use are the leading cause of preventable disease and death in the United States. The CDC estimates that more than 5 million deaths occur each year due to tobacco-related illnesses. Medical assistance with smoking and tobacco use cessation may reduce the prevalence of smoking and tobacco use, and ultimately prevent disease and improve health and quality of life.
\nExplore the percentage of adults age 18 and older who are current smokers or tobacco users and who received medical assistance with smoking and tobacco use cessation, including receipt of advice to quit and discussion of cessation medications and strategies.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Current Smokers and Tobacco Users Discussing Cessation Strategies: Ages 18 to 64 Years", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3280, "Indicator": "Rate", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 5.9, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate includes paid claims only.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3281, "Indicator": "Observed/Expected Ratio", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 0.7643, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS and managed care populations (3 MCOs). Rates were validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3283, "Indicator": "Rate", "state": "West Virginia", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 72.3, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (3 MCOs), representing 79 percent of the population. Rate excludes FFS population, representing 21 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is 6,878. Rate was validated by the state's EQRO.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3286, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 13.8, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate includes beneficiaries who were of appropriate age at any time during the measurement year. Rate does not exclude transfers from other hospitals, skilled nursing facilities, intermediate care facilities, and other health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3287, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 63.2, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate includes beneficiaries who were of appropriate age at any time during the measurement year. Rate does not exclude transfers from other hospitals, skilled nursing facilities, intermediate care facilities, and other health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3288, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.1, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate includes beneficiaries who were of appropriate age at any time during the measurement year. Rate does not exclude transfers from other hospitals, skilled nursing facilities, intermediate care facilities, and other health facilities.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3289, "Indicator": "Rate", "state": "West Virginia", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1.7, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate includes beneficiaries who were of appropriate age at any time during the measurement year. Rate does not exclude transfers from other hospitals, skilled nursing facilities, intermediate care facilities, and other health facilities.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3290, "Indicator": "Rate", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 62.1, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs).", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3293, "Indicator": "Rate", "state": "West Virginia", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 81.4, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS and managed care populations (3 MCOs). Rate was audited by HEDIS-certified auditors.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3304, "Indicator": "Rate", "state": "Wisconsin", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 61.5, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and 12 MCOs used the hybrid method. Measure-eligible population is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3307, "Indicator": "Acute Phase Treatment", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 66.5, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3308, "Indicator": "Continuation Phase Treatment", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 49.7, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3309, "Indicator": "Rate", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 50.3, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3310, "Indicator": "Rate", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 51.9, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3311, "Indicator": "Rate", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 58.1, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3317, "Indicator": "Rate", "state": "Wisconsin", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 63.1, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3318, "Indicator": "Rate", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Controlling High Blood Pressure: Ages 18 to 85", "measure_abbreviation": "CBP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 64, "number_of_states_reporting": 33, "median": 59.2, "percentile_25th": 52.6, "percentile_75th": 64.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "High blood pressure, or hypertension, increases the risk of heart disease and stroke—the leading causes of death in the United States. Controlling high blood pressure is an important step in preventing heart attacks, strokes, and kidney disease. It also reduces the risk of developing other serious conditions.
\nExplore the percentage of adults with a diagnosis of hypertension whose blood pressure was adequately controlled.
", "sc_measure_url": "/state-overviews/scorecard/controlling-high-blood-pressure/index.html", "default_rate_type": 1, "measure_description": "- Percentage who had a Diagnosis of Hypertension and Whose Blood Pressure was Adequately Controlled: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3319, "Indicator": "Rate", "state": "Wisconsin", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative & Hybrid", "state_rate": 64.8, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Rate was derived using both administrative and hybrid method data. Two MCOs used the administrative method and 12 MCOs used the hybrid method. Measure-eligible population is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3320, "Indicator": "Rate", "state": "Wisconsin", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 62.4, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3324, "Indicator": "30-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 26.5, "number_of_states_reporting": 41, "median": 22.5, "percentile_25th": 11.5, "percentile_75th": 30.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3325, "Indicator": "7-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence: Age 18 and Older", "measure_abbreviation": "FUA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 16.6, "number_of_states_reporting": 41, "median": 15.2, "percentile_25th": 7.8, "percentile_75th": 20.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for alcohol and other drug (AOD) abuse or dependence may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in substance abuse treatment and establishing continuity of care.
\nExplore the percentage of adults who had a follow-up visit with a mental health provider within the first week or the first 30 days of leaving an ED visit for AOD abuse or dependence.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Emergency Department (ED) Visits for Alcohol and Other Drug Abuse or Dependence with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3326, "Indicator": "30-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 62.2, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3327, "Indicator": "7-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 38.8, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3330, "Indicator": "30-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 55, "number_of_states_reporting": 40, "median": 52.1, "percentile_25th": 46.6, "percentile_75th": 63.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3331, "Indicator": "7-Day Follow-Up", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Emergency Department Visit for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.1, "number_of_states_reporting": 40, "median": 39.6, "percentile_25th": 30.5, "percentile_75th": 49.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Timely follow-up care after an emergency department (ED) visit for mental illness or intentional self-harm may reduce repeat ED visits, prevent hospital admissions, and improve health outcomes. The period immediately after the ED visit is important for engaging individuals in treatment and establishing continuity of care.
\nExplore the percentage of ED visits for adults with a principal diagnosis of mental illness or intentional self-harm with a follow-up visit for mental illness within 7 days of the ED visit and within 30 days of the ED visit.
", "sc_measure_url": "/state-overviews/scorecard/follow-after-emergency-department-visit-for-mental-illness-age-18-and-older/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Emergency Department (ED) Visits for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days of the ED Visit: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3332, "Indicator": "Rate", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Comprehensive Diabetes Care: Hemoglobin A1c Poor Control (>9.0%): Ages 18 to 75", "measure_abbreviation": "HPC-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 35, "number_of_states_reporting": 31, "median": 39, "percentile_25th": 47.8, "percentile_75th": 34.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is not available.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Among diabetic patients, a Hemoglobin A1c (HbA1c) level greater than 9.0% indicates poor control of diabetes. Poor control of diabetes is a risk factor for complications, including renal failure, blindness, and neurologic damage.
\nExplore the percentage of adults with Type 1 or Type 2 diabetes who had their HbA1c in poor control.
", "sc_measure_url": "/state-overviews/scorecard/comprehensive-diabetes-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Diabetes (Type 1 or Type 2) who had Hemoglobin A1c in Poor Control (>9.0%): Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3333, "Indicator": "Initiation", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Initiation and Engagement of Alcohol and Other Drug Abuse or Dependence Treatment: Age 18 and Older", "measure_abbreviation": "IET-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with a New Episode of Alcohol Abuse or Dependence who Initiated Alcohol or Other Drug Treatment within 14 Days of the Diagnosis: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 42.1, "number_of_states_reporting": 39, "median": 40.8, "percentile_25th": 36.8, "percentile_75th": 43.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "Alcohol Abuse or Dependence: Ages 18 to 64", "lead_in_snippet": "Treatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nTreatment for alcohol and other drug (AOD) abuse or dependence can improve health, productivity, and social outcomes. It can also save millions of dollars on health care and related costs.
\nRecommended care for individuals with a new episode of AOD abuse or dependence includes initiating treatment within 14 days of diagnosis (initiation rate) and then continued treatment with two or more additional AOD services or medication treatment within 34 days of the initiation visit (engagement rate).
\nExplore the percentage of adults with a new episode of AOD abuse or dependence who initiated timely treatment and continued engagement with treatment services. This measure reports the treatment initiation and engagement rates among beneficiaries with the following diagnoses:
\nThe National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3345, "Indicator": "", "state": "Wisconsin", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 58.5, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in Family Care and the Include, Respect, I Self-Direct (IRIS) Partnership. Funding sources include 1915(b)(c) waiver, HBCS waiver, and 1932(a) state plan program including HBCS waiver services. Denominator is the number of adults responding to the questions; number of adults included in the programs is 31,633. State used a proportionate sample by program/waiver. Data collection was interrupted by COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3346, "Indicator": "", "state": "Wisconsin", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 86.8, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in Family Care and the Include, Respect, I Self-Direct (IRIS) Partnership. Funding sources include 1915(b)(c) waiver, HBCS waiver, and 1932(a) state plan program including HBCS waiver services. Denominator is the number of adults responding to the questions; number of adults included in the programs is 31,633. State used a proportionate sample by program/waiver. Data collection was interrupted by COVID-19.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3347, "Indicator": "Observed/Expected Ratio", "state": "Wisconsin", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Plan All-Cause Readmissions: Ages 18 to 64", "measure_abbreviation": "PCR-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 1.039, "number_of_states_reporting": 37, "median": 1.0363, "percentile_25th": 1.1449, "percentile_75th": 0.9117, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include managed care population (14 MCOs), representing 64 percent of the population. Rates exclude FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Unplanned readmissions to the hospital within 30 days of discharge are associated with adverse patient outcomes, including higher mortality and higher health care costs. Readmissions may be prevented with coordination of care and support for patient self-management after discharge.
\nExplore the ratio of observed all-cause readmissions to expected readmissions among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Ratio of Observed All-Cause Readmissions to Expected Readmissions: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3349, "Indicator": "Rate", "state": "Wisconsin", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid", "methodology": "Hybrid", "state_rate": 76.5, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles. Denominator is the sample size; measure-eligible population is not available.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3351, "Indicator": "Rate", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Adherence to Antipsychotic Medications for Individuals with Schizophrenia: Age 18 and older", "measure_abbreviation": "SAA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 62.8, "number_of_states_reporting": 43, "median": 62.5, "percentile_25th": 56.6, "percentile_75th": 67, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Adherence to antipsychotics for the treatment of schizophrenia can reduce the risk of relapse or hospitalization.
\nExplore the percentage of adults with schizophrenia who remained on an antipsychotic medication for at least 80% of their treatment period.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia or Schizoaffective Disorder who were Dispensed and Remained on Antipsychotic Medication for at Least 80 Percent of their Treatment Period: Age 18 and older", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3352, "Indicator": "Rate", "state": "Wisconsin", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications: Ages 18 to 64", "measure_abbreviation": "SSD-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "ffy": 2020, "population": "Medicaid", "methodology": "Administrative", "state_rate": 78.8, "number_of_states_reporting": 44, "median": 80.3, "percentile_25th": 77.3, "percentile_75th": 82.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes managed care population (14 MCOs), representing 64 percent of the population. Rate excludes FFS population, representing 36 percent of the population, and Medicare-Medicaid Dual Eligibles.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Individuals with serious mental illness who use antipsychotics are at increased risk of developing diabetes. Lack of appropriate screening for diabetes among people with schizophrenia, schizoaffective disorder, or bipolar disorder who use antipsychotic medications can lead to adverse health outcomes if diabetes is not detected and treated.
\nExplore the percentage of adults with schizophrenia, schizoaffective disorder, or bipolar disorder who were dispensed an antipsychotic medication and had a diabetes screening test.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder who were Dispensed an Antipsychotic Medication and had a Diabetes Screening Test: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3358, "Indicator": "Rate", "state": "Wyoming", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Adult Body Mass Index Assessment: Ages 18 to 74", "measure_abbreviation": "ABA-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 24.7, "number_of_states_reporting": 39, "median": 85.6, "percentile_25th": 64.1, "percentile_75th": 91.7, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Monitoring of body mass index (BMI) helps providers identify adults who are overweight or obese and at increased risk for related health complications.
\nExplore the percentage of adults with an outpatient visit whose BMI value was documented in the medical record.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage who had an Outpatient Visit with a BMI Documented in the Medical Record: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3365, "Indicator": "Acute Phase Treatment", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.8, "number_of_states_reporting": 43, "median": 53.1, "percentile_25th": 47.5, "percentile_75th": 57.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 12 Weeks: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3366, "Indicator": "Continuation Phase Treatment", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Antidepressant Medication Management: Age 18 and Older", "measure_abbreviation": "AMM-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 9.5, "number_of_states_reporting": 42, "median": 37.3, "percentile_25th": 29.9, "percentile_75th": 41.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Effective management of antidepressant medication is an important standard of care for patients receiving treatment for depression. When individuals are first diagnosed with major depression, medication may be prescribed either alone or in combination with psychotherapy.
\nExplore the percentage of adults with a diagnosis of major depression who were treated with and remained on an antidepressant medication.
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage Diagnosed with Major Depression who were Treated with and Remained on Antidepressant Medication for 6 Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3367, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 58.4, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 49.6, "percentile_75th": 55.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 19-50", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 50", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3368, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 56.8, "number_of_states_reporting": 42, "median": 53.7, "percentile_25th": 50.9, "percentile_75th": 56.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Total (Ages 19-64)", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 1, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 19 to 64", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3369, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "Asthma Medication Ratio: Ages 19 to 64", "measure_abbreviation": "AMR-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 50.7, "number_of_states_reporting": 42, "median": 54.6, "percentile_25th": 50.7, "percentile_75th": 57.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 51-64", "lead_in_snippet": "Asthma affects nearly 19 million adults in the United States. Long-term asthma control medications are recommended for adults with persistent asthma. Uncontrolled asthma among adults can result in:
\nExplore the percentage of adults with persistent asthma who were dispensed appropriate asthma controller medications.
", "sc_measure_url": "/state-overviews/scorecard/asthma-medication-ratio-ages-19-64/index.html", "default_rate_type": 0, "measure_description": "- Percentage with Persistent Asthma who had a Ratio of Controller Medications to Total Asthma Medications of 0.50 or Greater: Ages 51 to 64", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3386, "Indicator": "Rate", "state": "Wyoming", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Breast Cancer Screening: Ages 50 to 74", "measure_abbreviation": "BCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 35.2, "number_of_states_reporting": 47, "median": 54.7, "percentile_25th": 50.4, "percentile_75th": 59.5, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 50 to 64", "lead_in_snippet": "Breast cancer causes approximately 42,000 deaths in the United States each year. The U.S. Preventive Services Task Force recommends that women between the ages of 50 to 74 undergo mammography screening once every two years. Early detection via mammography screening and subsequent treatment can reduce breast cancer mortality for women in this age range.
\nExplore the percentage of women ages 50 to 74 who had a mammogram to screen for breast cancer.
", "sc_measure_url": "/state-overviews/scorecard/breast-cancer-screening/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women who had a Mammogram to Screen for Breast Cancer: Ages 50 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3387, "Indicator": "LARC", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": "DS", "number_of_states_reporting": 31, "median": 1.9, "percentile_25th": 0.7, "percentile_75th": 2.7, "notes": "DS = Data suppressed because data cannot be displayed per the Centers for Medicare & Medicaid Services' cell-size suppression policy, which prohibits the direct reporting of data for beneficiary and record counts of 1 to 10 and values from which users can derive values of 1 to 10.", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "No", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3388, "Indicator": "LARC", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 17.9, "number_of_states_reporting": 34, "median": 12.6, "percentile_25th": 9.5, "percentile_75th": 15.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Long-Acting Reversible Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 4, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3389, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 11.9, "number_of_states_reporting": 33, "median": 11.9, "percentile_25th": 8.7, "percentile_75th": 13, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "3-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 3 Days of Delivery: Ages 21 to 44", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3390, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: Postpartum Women Ages 21 to 44", "measure_abbreviation": "CCP-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 24.7, "number_of_states_reporting": 34, "median": 41.6, "percentile_25th": 35.2, "percentile_75th": 46, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "60-Days Postpartum", "lead_in_snippet": "Access to effective contraceptive care during the postpartum period can improve birth spacing and timing and improve the health outcomes of women and children.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Postpartum Women Provided a Most Effective or Moderately Effective Method of Contraception Within 60 Days of Delivery: Ages 21 to 44", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3399, "Indicator": "Rate", "state": "Wyoming", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Cervical Cancer Screening: Ages 21 to 64", "measure_abbreviation": "CCS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 38.1, "number_of_states_reporting": 47, "median": 56.7, "percentile_25th": 49.3, "percentile_75th": 62.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Approximately 14,000 new cases of cervical cancer and 4,300 deaths due to cervical cancer occur in the United States each year. When precancerous lesions or early stage cancer are detected through screening, cervical cancer can usually be prevented or treated effectively.
\nExplore the percentage of women ages 21 to 64 who received recommended regular screening for cervical cancer.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women Screened for Cervical Cancer: Ages 21 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3400, "Indicator": "LARC", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 6.2, "number_of_states_reporting": 31, "median": 5.1, "percentile_25th": 3.6, "percentile_75th": 6.1, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Long-Acting Reversible Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3401, "Indicator": "Most or Moderately Effective Contraceptive", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Contraceptive Care: All Women Ages 21 to 44", "measure_abbreviation": "CCW-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 17.6, "number_of_states_reporting": 31, "median": 24.5, "percentile_25th": 23, "percentile_75th": 28.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Increasing access to effective forms of contraception is a strategy for reducing unintended pregnancy.
\nExplore the percentage of women ages 21 to 44 at risk of unintended pregnancy who were provided a most or moderately effective method of contraception or a long-acting reversible method of contraception (LARC).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Women at Risk for Unintended Pregnancy Provided a Most Effective or Moderately Effective Method of Contraception: Ages 21 to 44", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3406, "Indicator": "Rate", "state": "Wyoming", "domain": "Primary Care Access and Preventive Care", "reporting_program": "Adult Core Set", "measure_name": "Chlamydia Screening in Women Ages 21 to 24", "measure_abbreviation": "CHL-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 42.1, "number_of_states_reporting": 48, "median": 60.5, "percentile_25th": 53.8, "percentile_75th": 67.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Chlamydia is the most commonly reported sexually transmitted infection and easy to cure when it is detected. However, most people have no symptoms and are not aware they are infected. Left untreated, chlamydia can affect a woman's ability to have children.
\nExplore the percentage of women ages 21 to 24 who were identified as sexually active and who had at least one test for chlamydia.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of Sexually Active Women Screened for Chlamydia: Ages 21 to 24", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3413, "Indicator": "Rate", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Concurrent Use of Opioids and Benzodiazepines: Age 18 and older", "measure_abbreviation": "COB-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 1, "number_of_states_reporting": 27, "median": 16.3, "percentile_25th": 21.6, "percentile_75th": 11.2, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "The concurrent use of opioids and benzodiazepines can increase the risk for overdose and death and result in other adverse events, such as difficulty breathing. The Centers for Disease Control and Prevention (CDC) recommends that prescribers should avoid concurrent prescriptions of opioids and benzodiazepines.
\nExplore the percentage of adults age 18 and older with concurrent use of prescription opioids and benzodiazepines for 30 or more cumulative days during the measurement year. Adults with a cancer diagnosis, sickle cell disease diagnosis, or in hospice are excluded.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage with Concurrent Use of Prescription Opioids and Benzodiazepines: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3416, "Indicator": "30-Day Follow-Up", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 11, "number_of_states_reporting": 48, "median": 54.7, "percentile_25th": 40.5, "percentile_75th": 65.6, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 0, "measure_description": "- 30-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 30 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "FALSE", "is_scorecard_measure": "TRUE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3417, "Indicator": "7-Day Follow-Up", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Follow-Up After Hospitalization for Mental Illness: Age 18 and Older", "measure_abbreviation": "FUH-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 6, "number_of_states_reporting": 48, "median": 33.1, "percentile_25th": 24.1, "percentile_75th": 44.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rates include FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Follow-up care after hospitalization for mental illness or intentional self-harm helps improve health outcomes and prevent readmissions. Recommended post-discharge treatment includes a visit with a mental health provider within 30 days after discharge. Ideally, patients should see a mental health provider within 7 days after discharge.
\nExplore the percentage of discharges for adults who were hospitalized for treatment of selected mental illness or intentional self-harm diagnoses and had a follow-up visit with a mental health provider within 7 days after discharge and within 30 days after discharge.
", "sc_measure_url": "/state-overviews/scorecard/follow-up-after-hospitalization-mental-illness-age-18/index.html", "default_rate_type": 1, "measure_description": "- 7-Day Follow-Up Rate: Percentage of Hospitalizations for Mental Illness or Intentional Self-Harm with a Follow-Up Visit Within 7 Days after Discharge: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3427, "Indicator": "", "state": "Wyoming", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 92, "number_of_states_reporting": 25, "median": 92.9, "percentile_25th": 89.6, "percentile_75th": 93.9, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Comprehensive Waiver and Supports waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 1,756. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who make choices about their everyday lives, including their daily schedule, how to spend money, and free time activities", "rate_order": 2, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3428, "Indicator": "", "state": "Wyoming", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 70.5, "number_of_states_reporting": 25, "median": 68.6, "percentile_25th": 61.2, "percentile_75th": 74.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Comprehensive Waiver and Supports waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 1,756. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Percentage of people who make choices about their life decisions, including their residence, work, day activity, staff, and roommates", "rate_order": 1, "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3429, "Indicator": "", "state": "Wyoming", "domain": "Long-Term Services and Supports", "reporting_program": "Adult Core Set", "measure_name": "National Core Indicators Survey: Age 18 and Older", "measure_abbreviation": "NCIDDS-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of people who reported they always have a way to get places when they need to go somewhere", "ffy": 2020, "population": "Medicaid", "methodology": "NCI In-Person Survey", "state_rate": 96.2, "number_of_states_reporting": 25, "median": 95, "percentile_25th": 92, "percentile_75th": 96.8, "notes": "", "source": "Mathematica analysis of data submitted by states to NASDDS/HSRI (The NCI National Team) through the Online Data Entry System (ODESA) during the July 1, 2019 through June 30, 2020 data collection period.", "state_specific_comments": "Rates include adults in the Comprehensive Waiver and Supports waiver. Funding source is HCBS waiver. Denominator is the number of adults responding to the questions; number of adults included in the waivers is 1,756. State used a random sample.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "The National Core Indicators (NCI) provide information on beneficiaries experience and self-reported outcomes of long-term services and supports for individuals with intellectual and developmental disabilities (I/DD) and their families. State-level performance on three measures of I/DD beneficiary experience are reported for FFY 2020. These measures are: (1) Life Decisions Scale (percentage of people who reported they chose or had some input in choosing their residence, work, day activity, staff, and roommates); (2) Everyday Choices Scale (percentage of people who reported they decided or had help deciding their daily schedule, how to spend money, and how to spend free time); and (3) Always Has a Way to Get Places measure (percentage of people who reported they always have a way to get places when they need to go somewhere).
", "sc_measure_url": "", "default_rate_type": 0, "measure_description": "- Percentage of people who reported they always have a way to get places when they need to go somewhere", "rate_order": 3, "default_rate_def_1": "FALSE", "is_scorecard_measure": "FALSE", "default_count": 0, "default_rate_definition": "FALSE" }, { "Obs": 3430, "Indicator": "Rate", "state": "Wyoming", "domain": "Behavioral Health Care", "reporting_program": "Adult Core Set", "measure_name": "Use of Opioids at High Dosage in Persons Without Cancer: Age 18 and Older", "measure_abbreviation": "OHD-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Percentage Without Cancer who Received Prescriptions for Opioids with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 23.9, "number_of_states_reporting": 28, "median": 6.5, "percentile_25th": 9.6, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Opioid use is a growing concern in the United States. The opioid epidemic continues to highlight the need for both preventing inappropriate prescribing and providing access to high quality treatment.
\nHigh dosage opioid use by people without cancer is an indicator of potential overuse and linked to an increased risk of morbidity and mortality.
\nExplore the percentage of adults who received prescriptions for opioids at high dosage over a period of 90 days or more. Adults with a cancer diagnosis, sickle cell diagnosis, or in hospice are excluded.
", "sc_measure_url": "/state-overviews/scorecard/opioid-use-at-high-dosage-without-cancer/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Adults Without Cancer with Two or More Opioid Prescription Claims with an Average Daily Dosage Greater than or Equal to 90 Morphine Milligram Equivalents Over 90 Consecutive Days or More: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3432, "Indicator": "Rate", "state": "Wyoming", "domain": "Maternal and Perinatal Health", "reporting_program": "Adult Core Set", "measure_name": "Prenatal and Postpartum Care: Postpartum Care", "measure_abbreviation": "PPC-AD", "measure_type": "Higher rates are better for this measure", "measure_description_orig": "Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 39.9, "number_of_states_reporting": 39, "median": 72.3, "percentile_25th": 65.7, "percentile_75th": 77, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Medicaid is the largest payer for maternity care in the United States. The program has an important role to play in improving maternal and perinatal health outcomes. Timely postpartum visits provide an opportunity to assess a woman's physical recovery from pregnancy and childbirth.
\nPostpartum visits provide an opportunity to address:
\nExplore the percentage of women delivering a live birth who had a timely postpartum care visit.
", "sc_measure_url": "/state-overviews/scorecard/postpartum-care/index.html", "default_rate_type": 1, "measure_description": "- Percentage of Women Delivering a Live Birth who had a Postpartum Care Visit on or Between 7 and 84 Days after Delivery", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3435, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 01: Diabetes Short-Term Complications Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI01-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 26.5, "number_of_states_reporting": 36, "median": 20.1, "percentile_25th": 26.7, "percentile_75th": 15.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "Without access to high quality outpatient diabetes care, certain diabetes conditions can become life-threatening. These complications may result in costly and avoidable inpatient hospital admissions. Inpatient hospital admissions for these complications can be an indicator that diabetes is not being properly prevented or managed.
\nExplore inpatient hospital admission rates per 100,000 beneficiary months for short-term complications of diabetes.
", "sc_measure_url": "/state-overviews/scorecard/diabetes-short-term-complications-admission-rate/index.html", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Diabetes Short-Term Complications per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "TRUE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3436, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 05: Chronic Obstructive Pulmonary Disease (COPD) or Asthma in Older Adults Admission Rate: Age 40 and Older", "measure_abbreviation": "PQI05-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 99.9, "number_of_states_reporting": 31, "median": 56.4, "percentile_25th": 85.2, "percentile_75th": 41.3, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 40 to 64", "lead_in_snippet": "COPD is one of the most common chronic diseases in the United States, and is currently the third leading cause of death in the U.S. population. Hospital admissions for COPD and asthma can often be avoided through high quality outpatient care.
\nExplore the number of inpatient hospital admissions to treat COPD or asthma among adults age 40 and older.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Chronic Obstructive Pulmonary Disease (COPD) or Asthma per 100,000 Beneficiary Months: Ages 40 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3437, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 08: Heart Failure Admission Rate: Age 18 and Older", "measure_abbreviation": "PQI08-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 10.2, "number_of_states_reporting": 31, "median": 24.4, "percentile_25th": 34.5, "percentile_75th": 19.4, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "Ages 18 to 64", "lead_in_snippet": "An estimated 5.7 million people in the United States have congestive heart failure (CHF). The most common causes of CHF are coronary artery disease, high blood pressure, and diabetes, all of which can be treated, controlled, and monitored in outpatient settings. Inpatient hospital admissions for heart failure can be an indicator that these conditions are not being properly prevented or managed.
\nExplore the number of inpatient hospital admissions for heart failure among adults.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Heart Failure per 100,000 Beneficiary Months: Ages 18 to 64", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" }, { "Obs": 3438, "Indicator": "Rate", "state": "Wyoming", "domain": "Care of Acute and Chronic Conditions", "reporting_program": "Adult Core Set", "measure_name": "PQI 15: Asthma in Younger Adults Admission Rate: Ages 18 to 39", "measure_abbreviation": "PQI15-AD", "measure_type": "Lower rates are better for this measure", "measure_description_orig": "Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "ffy": 2020, "population": "Medicaid & Dual Eligibles", "methodology": "Administrative", "state_rate": 12.1, "number_of_states_reporting": 31, "median": 6.5, "percentile_25th": 7.8, "percentile_75th": 3.9, "notes": "", "source": "Mathematica analysis of MACPro reports for the FFY 2020 reporting cycle as of June 18, 2021.", "state_specific_comments": "Rate includes FFS population.", "rate_used_in_calculating": "Yes", "stratification": "", "lead_in_snippet": "Asthma is one of the most common reasons for hospital admissions and emergency room visits among younger adults. These events are generally considered preventable with proper oversight and treatment in outpatient settings.
\nExplore the number of inpatient hospital admissions to treat asthma among adults age 18 to 39.
", "sc_measure_url": "", "default_rate_type": 1, "measure_description": "- Inpatient Hospital Admissions for Asthma per 100,000 Beneficiary Months: Ages 18 to 39", "rate_order": ".", "default_rate_def_1": "TRUE", "is_scorecard_measure": "FALSE", "default_count": 1, "default_rate_definition": "TRUE" } ]